1
|
Cui Y, Zhou Y, Gao Y, Ma X, Wang Y, Zhang X, Zhou T, Chen S, Lu L, Zhang Y, Chang X, Tong A, Li Y. Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction. J Endocrinol Invest 2024; 47:1191-1203. [PMID: 38206552 DOI: 10.1007/s40618-023-02239-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/02/2023] [Accepted: 11/02/2023] [Indexed: 01/12/2024]
Abstract
OBJECTIVE The existing prediction models for metastasis in pheochromocytomas/paragangliomas (PPGLs) showed high heterogeneity in different centers. Therefore, this study aimed to establish new prediction models integrating multiple variables based on different algorithms. DESIGN AND METHODS Data of patients with PPGLs undergoing surgical resection at the Peking Union Medical College Hospital from 2007 to 2022 were collected retrospectively. Patients were randomly divided into the training and testing sets in a ratio of 7:3. Subsequently, decision trees, random forest, and logistic models were constructed for metastasis prediction with the training set and Cox models for metastasis-free survival (MFS) prediction with the total population. Additionally, Ki-67 index and tumor size were transformed into categorical variables for adjusting models. The testing set was used to assess the discrimination and calibration of models and the optimal models were visualized as nomograms. Clinical characteristics and MFS were compared between patients with and without risk factors. RESULTS A total of 198 patients with 59 cases of metastasis were included and classified into the training set (n = 138) and testing set (n = 60). Among all models, the logistic regression model showed the best discrimination for metastasis prediction with an AUC of 0.891 (95% CI, 0.793-0.990), integrating SDHB germline mutations [OR: 96.72 (95% CI, 16.61-940.79)], S-100 (-) [OR: 11.22 (95% CI, 3.04-58.51)], ATRX (-) [OR: 8.42 (95% CI, 2.73-29.24)] and Ki-67 ≥ 3% [OR: 7.98 (95% CI, 2.27-32.24)] evaluated through immunohistochemistry (IHC), and tumor size ≥ 5 cm [OR: 4.59 (95% CI, 1.34-19.13)]. The multivariate Cox model including the above risk factors also showed a high C-index of 0.860 (95% CI, 0.810-0.911) in predicting MFS after surgery. Furthermore, patients with the above risk factors showed a significantly poorer MFS (P ≤ 0.001). CONCLUSIONS Models established in this study provided alternative and reliable tools for clinicians to predict PPGLs patients' metastasis and MFS. More importantly, this study revealed for the first time that IHC of ATRX could act as an independent predictor of metastasis in PPGLs.
Collapse
Affiliation(s)
- Y Cui
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - Y Zhou
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - Y Gao
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - X Ma
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - Y Wang
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - X Zhang
- Department of Urology Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - T Zhou
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - S Chen
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - L Lu
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - Y Zhang
- Medical Research Center, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| | - X Chang
- Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.
| | - A Tong
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China.
| | - Y Li
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People's Republic of China
| |
Collapse
|
2
|
Koo BB, Abdelfattah A, Eysa A, Lu L. The Melanocortin and Endorphin Neuropeptides in Patients with Restless Legs Syndrome. Ann Neurol 2024; 95:688-699. [PMID: 38308537 DOI: 10.1002/ana.26876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 11/13/2023] [Accepted: 01/10/2024] [Indexed: 02/04/2024]
Abstract
OBJECTIVE Based upon similarities between the urge to move and sensory discomfort of restless legs syndrome (RLS) and properties of melanocortin hormones, including their incitement of movement and hyperalgesia, we assessed plasma and cerebrospinal fluid (CSF) α-melanocyte-stimulating hormone (α-MSH) and β-endorphin in RLS patients and controls. METHODS Forty-two untreated moderate-to-severe RLS patients and 44 matched controls underwent venipuncture at 19:00, 20:30, and 22:00; 37 RLS and 36 controls had lumbar puncture at 21:30. CSF and plasma were analyzed for pro-opiomelanocortin (POMC), adrenocorticotropin hormone (ACTH), α-MSH, β-MSH, and β-endorphin by immunoassay. RLS severity was assessed by International RLS Study Group Severity Scale. RESULTS RLS participants were 52.7 ± 12.0 years old, 61.9% were women, 21.4% had painful RLS, and RLS severity was 24.8 ± 9.0. Controls had similar age and sex. Plasma ACTH, α-MSH, and β-endorphin were similar between groups. Plasma POMC was significantly greater in RLS than controls (17.0 ± 11.5 vs 12.7 ± 6.1fmol/ml, p = 0.048). CSF ACTH was similar between groups. CSF β-MSH was significantly higher in painful than nonpainful RLS or controls (48.2 ± 24.8 vs 32.1 ± 14.8 vs 32.6 ± 15.2pg/ml, analysis of variance [ANOVA] p = 0.03). CSF α-MSH was higher in RLS than controls (34.2 ± 40.9 vs 20.3 ± 11.0pg/ml, p = 0.062). CSF β-EDP was lowest in painful RLS, intermediate in nonpainful RLS, and highest in controls (8.0 ± 3.4 vs 10.8 ± 3.1 vs 12.3 ± 5.0pg/ml, ANOVA p = 0.049). The ratio of the sum of CSF α- and β-MSH to CSF β-endorphin was highest, intermediate, and lowest in painful RLS, nonpainful RLS, and controls (p = 0.007). INTERPRETATION CSF β-MSH is increased and CSF β-endorphin decreased in RLS patients with painful symptoms. ANN NEUROL 2024;95:688-699.
Collapse
Affiliation(s)
- Brian B Koo
- Department of Neurology, Yale University, New Haven, CT, USA
| | | | - Athar Eysa
- Department of Internal Medicine, Morristown Medical Center, Morristown, NJ, USA
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale University, New Haven, CT, USA
| |
Collapse
|
3
|
Zhang X, Gao Y, Lu L, Cao Y, Zhang W, Sun B, Wu X, Tong A, Chen S, Wang X, Mao J, Nie M. Targeted long-read sequencing for comprehensive detection of CYP21A2 mutations in patients with 21-hydroxylase deficiency. J Endocrinol Invest 2024; 47:833-841. [PMID: 37815751 DOI: 10.1007/s40618-023-02197-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 09/08/2023] [Indexed: 10/11/2023]
Abstract
BACKGROUND 21-Hydroxylase deficiency (21-OHD) is caused by pathogenic CYP21A2 variations. CYP21A2 is arranged in tandem with its highly homologous pseudogene CYP21A1P; therefore, it is prone to mismatch and rearrangement, producing different types of complex variations. There were few reports on using only one method to detect different CYP21A2 variants simultaneously. AIMS Targeted long-read sequencing method was used to detect all types of CYP21A2 variants in a series of patients with 21-OHD. METHODS A total of 59 patients with 21-OHD were enrolled from Peking Union Medical College Hospital. Long-range locus-specific PCR and long-read sequencing (LRS) were performed to detect the pathogenic variants in CYP21A2. RESULTS Copy-number variants of CYP21A2 were found in 25.4% of patients, including 5.1% with 3 copies of CYP21A2, 16.9% with 1 copy of CYP21A2, and 3.4% with 0 copy of CYP21A2. The remaining 74.6% of patients had 2 copies of CYP21A2. Pathogenic variants were identified in all 121 alleles of 59 patients. Specifically, single-nucleotide variants and small insertions/deletions (< 50 bp) were detected in 79 alleles, of which conversed from CYP21A1P were detected in 63 alleles, and rare variants were found in the other 16 alleles. Large gene conversions (> 50 bp) from pseudogene were detected in 10 alleles, and different chimeric genes (CYP21A1P/CYP21A2 or TNXA/TNXB) formed by large deletions were detected in 32 alleles. Of all variants, p.I173N was the most common variant (19.0%). CONCLUSIONS Our study demonstrated that targeted long-read sequencing is a comprehensive method for detecting CYP21A2 variations, which is helpful for genetic diagnosis in 21-OHD patients.
Collapse
Affiliation(s)
- X Zhang
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - Y Gao
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - L Lu
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - Y Cao
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - W Zhang
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - B Sun
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - X Wu
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - A Tong
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - S Chen
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - X Wang
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - J Mao
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
| | - M Nie
- Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission (NHC), Peking Union Medical College Hospital), Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
| |
Collapse
|
4
|
Mezzacappa C, Wang Z, Lu L, Risch H, Taddei T, Yu H. Detection of hepatocellular carcinoma methylation markers in salivary DNA. Biosci Rep 2024; 44:BSR20232063. [PMID: 38457142 PMCID: PMC10958141 DOI: 10.1042/bsr20232063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 02/21/2024] [Accepted: 03/08/2024] [Indexed: 03/09/2024] Open
Abstract
BACKGROUND Alterations to DNA methylation have been identified in both hepatocellular carcinoma (HCC) tumor and circulating DNA from affected individuals. These markers have potential utility in HCC screening. Adherence to HCC screening is poor and acceptable HCC screening tests are needed. METHODS A feasibility study was performed on a subset of case patients and control subjects from a prior study of risk factors for HCC. Case patients (n=12) included adults aged 47-85 years with a first diagnosis of HCC between 2011 and 2016 and without viral hepatitis. Control subjects (n=12) were matched on age, sex, and state of residence. Participants provided saliva samples for DNA genotyping. Log fold change in salivary DNA methylation at 1359 CpG sites representing 25 candidate genes previously associated with HCC was compared across case patients and control subjects. RESULTS The quantity of DNA ranged from 9.65 to 257.79 μg. The purity of DNA isolates was good, with mean OD260/280 ratio of 1.78 (SD: 0.14). Of 25 candidate genes, 16 had at ≥1 CpG site with detectable differences in methylation across HCC case patients and control subjects. Sites differentially methylated in HCC case patients included genes encoding tumor suppressors (PRDM2, RUNX3, p15/16, and RASSF1/5), regulators of cell cycle progression (DAPK1 and TP73), and DNA repair (MGMT and GSTP1). No associations met the significance threshold 3.7 × 10-5 required for multiple comparisons. CONCLUSIONS Salivary DNA may be a feasible alternative to blood samples in the era of novel DNA-based screening tests for HCC. The ease of saliva-based testing supports further investigation of its potential.
Collapse
Affiliation(s)
- Catherine Mezzacappa
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States
| | - Zhanwei Wang
- University of Hawai’i Cancer Consortium, Honolulu, HI, United States
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States
| | - Harvey Risch
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States
| | - Tamar Taddei
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States
- VA Connecticut Healthcare System, West Haven, CT, United States
| | - Herbert Yu
- University of Hawai’i Cancer Consortium, Honolulu, HI, United States
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States
| |
Collapse
|
5
|
Habeshian TS, Peeri NC, De Vivo I, Schouten LJ, Shu XO, Cote ML, Bertrand KA, Chen Y, Clarke MA, Clendenen TV, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, Gallagher G, Gierach GL, Goodman MT, Jordan SJ, La Vecchia C, Lacey JV, Levi F, Liao LM, Lipworth L, Lu L, Matías-Guiu X, Moysich KB, Mutter GL, Na R, Naduparambil J, Negri E, O'Connell K, O'Mara TA, Onieva Hernández I, Palmer JR, Parazzini F, Patel AV, Penney KL, Prizment AE, Ricceri F, Risch HA, Sacerdote C, Sandin S, Stolzenberg-Solomon RZ, van den Brandt PA, Webb PM, Wentzensen N, Wijayabahu AT, Wilkens LR, Xu W, Yu H, Zeleniuch-Jacquotte A, Zheng W, Du M, Setiawan VW. Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiol Biomarkers Prev 2024:742011. [PMID: 38530242 DOI: 10.1158/1055-9965.epi-23-1444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/25/2024] [Accepted: 03/22/2024] [Indexed: 03/27/2024] Open
Abstract
BACKGROUND The incidence rates of endometrial cancer (EC) are increasing, which may partly be explained by the rising prevalence of obesity, an established risk factor for EC. Hypertension, another component of metabolic syndrome, is also increasing in prevalence, and emerging evidence suggests that it may be associated with the development of certain cancers. The role of hypertension independent of other components of metabolic syndrome in the etiology of EC remains unclear. In this study we evaluated hypertension as an independent risk factor for EC and whether this association is modified by other established risk factors. METHODS We included 15,631 EC cases and 42,239 controls matched on age, race, and study-specific factors from 29 studies in the Epidemiology of Endometrial Cancer Consortium. We used multivariable unconditional logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the association between hypertension and EC and whether this association differed by study design, race/ethnicity, body mass index, diabetes status, smoking status, or reproductive factors. RESULTS Hypertension was associated with an increased risk of EC (OR=1.14, 95% CI:1.09-1.19). There was significant heterogeneity by study design (Phet<0.01), with a stronger magnitude of association observed among case-control vs. cohort studies. Stronger associations were also noted for pre-/peri-menopausal women and never users of postmenopausal hormone therapy. CONCLUSIONS Hypertension is associated with EC risk independently from known risk factors. Future research should focus on biologic mechanisms underlying this association. IMPACT This study provides evidence that hypertension may be an independent risk factor for EC.
Collapse
Affiliation(s)
| | - Noah C Peeri
- Memorial Sloan Kettering Cancer Center, New York, NY, United States
| | | | - Leo J Schouten
- Maastricht University Medical Centre, Maastricht, Netherlands
| | - Xiao-Ou Shu
- Vanderbilt University Medical Center, Nashville, TN, United States
| | - Michele L Cote
- Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, United States
| | | | - Yu Chen
- New York University School of Medicine, New York, United States
| | - Megan A Clarke
- National Cancer Institute, Rockville, Maryland, United States
| | - Tess V Clendenen
- New York University School of Medicine, New York, NY, United States
| | - Linda S Cook
- Colorado School of Public Health, Aurora, CO, United States
| | - Laura Costas
- Institut Català d'Oncologia, L'Hospitalet de Llobregat, Catalunya, Spain
| | | | - Jo L Freudenheim
- University at Buffalo, State University of New York, Buffalo, NY, United States
| | | | - Grace Gallagher
- Memorial Sloan Kettering Cancer Center, New York, NY, United States
| | | | - Marc T Goodman
- Cedars-Sinai Medical Center, Los Angeles, California, United States
| | | | | | | | - Fabio Levi
- University of Lausanne, Lausanne, Switzerland
| | - Linda M Liao
- National Cancer Institute, Bethesda, MD, United States
| | | | - Lingeng Lu
- Yale University, New Haven, CT, United States
| | - Xavier Matías-Guiu
- Institut d'Investigació Biomédica de Bellvitge, Hospitalet de Llobregat, Barcelona, Barcelona, Spain
| | | | | | - Renhua Na
- QIMR Berghofer Medical Research Institute, BRISBANE, Australia
| | | | - Eva Negri
- University of Bologna, Bologna, Italy
| | - Kelli O'Connell
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
| | - Tracy A O'Mara
- QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
| | | | | | | | - Alpa V Patel
- American Cancer Society, Kennesaw, GA, United States
| | - Kathryn L Penney
- Brigham and Women's Hospital/Harvard Medical School, Boston, MA, United States
| | - Anna E Prizment
- University of Minnesota Medical School, Minneapolis, MN, United States
| | | | - Harvey A Risch
- Yale School of Public Health, New Haven, CT, United States
| | - Carlotta Sacerdote
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Turin, Italy
| | | | | | | | - Penelope M Webb
- QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
| | | | | | - Lynne R Wilkens
- University of Hawaii Cancer Center, Honolulu, HI, United States
| | | | - Herbert Yu
- University of Hawaii System, Honolulu, HI, United States
| | | | - Wei Zheng
- Vanderbilt University Medical Center, Nashville, TN, United States
| | - Mengmeng Du
- Memorial Sloan Kettering Cancer Center, New York, NY, United States
| | | |
Collapse
|
6
|
Wu Z, Jia X, Lu L, Xu C, Pang Y, Peng S, Liu M, Wu Y. Multi-center Dose Prediction Using Attention-aware Deep learning Algorithm Based on Transformers for Cervical Cancer Radiotherapy. Clin Oncol (R Coll Radiol) 2024:S0936-6555(24)00119-5. [PMID: 38631974 DOI: 10.1016/j.clon.2024.03.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Revised: 02/22/2024] [Accepted: 03/21/2024] [Indexed: 04/19/2024]
Abstract
AIMS Accurate dose delivery is crucial for cervical cancer volumetric modulated arc therapy (VMAT). We aimed to develop a robust deep-learning (DL) algorithm for fast and accurate dose prediction of cervical cancer VMAT in multicenter datasets and then explore the feasibility of the DL algorithm to endometrial cancer VMAT with different prescriptions. MATERIALS AND METHODS We proposed the AtTranNet algorithm for three-dimensional dose prediction. A total of 367 cervical patients were enrolled in this study. Three hundred twenty-two cervical patients from 3 centers were randomly divided into 70%, 10%, and 20% as training, validation, and testing sets, respectively. Forty-five cervical patients from another center were selected for external testing. Moreover, 70 patients of endometrial cancer with different prescriptions were further selected to test the model. Prediction precision was evaluated by dosimetric difference, dose map, and dose-volume histogram metrics. RESULTS The prediction results were all clinically acceptable. The mean absolute error within the body in internal testing was 0.66 ± 0.63%. The maximum |δD| for planning target volume was observed in D98, which is 1.24 ± 2.73 Gy. The maximum |δD| for organs at risk was observed in Dmean of bladder, which is 4.79 ± 3.14 Gy. The maximum |δV| were observed in V40 of pelvic bones, which is 4.77 ± 4.48%. CONCLUSION AtTranNet showed the feasibility and reasonable accuracy in the dose prediction for cervical cancer in multiple centers. The model can also be generalized for endometrial cancer with different prescriptions without any transfer learning.
Collapse
Affiliation(s)
- Z Wu
- Department of Digital Medicine, School of Biomedical Engineering and Medical Imaging, Army Medical University, Chongqing, PR China; Department of Radiotherapy, Zigong First People's Hospital, Sichuan, PR China; Yu-Yue Pathology Research Center, Jinfeng Laboratory, Chongqing, PR China
| | - X Jia
- Department of Radiotherapy, The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, PR China
| | - L Lu
- Department of Radiotherapy, Tongling People's Hospital, Anhui, PR China
| | - C Xu
- Department of Radiotherapy, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, PR China
| | - Y Pang
- Department of Radiotherapy, Zigong First People's Hospital, Sichuan, PR China
| | - S Peng
- Department of Radiotherapy, Zigong First People's Hospital, Sichuan, PR China
| | - M Liu
- Department of Digital Medicine, School of Biomedical Engineering and Medical Imaging, Army Medical University, Chongqing, PR China.
| | - Y Wu
- Department of Digital Medicine, School of Biomedical Engineering and Medical Imaging, Army Medical University, Chongqing, PR China; Yu-Yue Pathology Research Center, Jinfeng Laboratory, Chongqing, PR China.
| |
Collapse
|
7
|
Jiang WJ, Ao S, Cui YY, Lu L, Wang CN. [Clinicopathological and molecular characteristics of esophageal carcinoma with ductal differentiation: analysis of 17 cases]. Zhonghua Bing Li Xue Za Zhi 2024; 53:276-281. [PMID: 38433056 DOI: 10.3760/cma.j.cn112151-20230720-00017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/05/2024]
Abstract
Objective: To investigate the clinicopathological features and molecular genetic characteristics of esophageal carcinoma with ductal differentiation, and to summarize the experiences in its diagnosis and treatment. Methods: A total of 17 cases of esophageal carcinoma with ductal differentiation diagnosed in Ningbo Clinical Pathological Diagnosis Center, Ningbo, China from June 2011 to December 2022 were collected. The clinical information and pathological diagnosis was reviewed. The tumor histological features and immunohistochemical results were analyzed. The next-generation sequencing was performed to detect and analyze the gene mutations in tumor samples. Results: The 17 patients included in this study were 54-77 years old, with a median age of 66 years. There were 16 males and 1 female. Among them, 9 cases were mainly carcinoma with ductal differentiation. The squamous epithelium on the tumor's surface was accompanied by high-grade intraepithelial neoplasia. The tumor and atypical squamous epithelium were transitional, and the focus was accompanied by various proportions of squamous cell carcinoma component (less than 10%). The other 8 cases were mostly squamous cell carcinoma, basaloid squamous cell carcinoma or sarcomatoid carcinoma with various degrees of tumor specific differentiation and focal area of carcinoma with ductal differentiation (less than 10%). The tumor cells in the area with ductal differentiation were mainly arranged in small tubes, while the tubes showed a double-layer structure, including the inner cells and outer cells of the lumen. Immunohistochemical results showed that the outer cells of the tumorous tubules expressed p63, p40, CK5/6 and CK34βE12, while the inner cells expressed CK7. Compared with esophageal squamous cell carcinoma reported in the literature, the frequency of gene mutations such as MYC (P=0.002), TP63 (P=0.002), CDKN1C (P=0.002) and NFE2L2 (P=0.045) was significantly lower in this group of cases. At the signaling pathway level, the mutation frequency of NOTCH signaling pathway (P=0.041) was significantly higher, while the mutation frequencies of NRF2 pathway (P=0.013) and PI3K pathway (P=0.009) were significantly lower than that of esophageal squamous cell carcinoma. Conclusion: Esophageal carcinoma with ductal differentiation is a type of esophageal carcinoma with unique morphology, and its molecular changes are also significantly different from those of conventional esophageal squamous cell carcinoma.
Collapse
Affiliation(s)
- W J Jiang
- Ningbo Clinical Pathology Diagnosis Center, Ningbo 315021, China
| | - S Ao
- Ningbo Clinical Pathology Diagnosis Center, Ningbo 315021, China
| | - Y Y Cui
- Ningbo Clinical Pathology Diagnosis Center, Ningbo 315021, China
| | - L Lu
- Ningbo Clinical Pathology Diagnosis Center, Ningbo 315021, China
| | - C N Wang
- Ningbo Clinical Pathology Diagnosis Center, Ningbo 315021, China
| |
Collapse
|
8
|
Yao Y, Tang J, Li Z, Chen S, Li Y, Meng H, Lu L. Perceived social support mediates the effect of COVID-19 pandemic on job adaptation disorders of workers: An exploratory cross-sectional study. Medicine (Baltimore) 2024; 103:e37118. [PMID: 38306538 PMCID: PMC10843244 DOI: 10.1097/md.0000000000037118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2022] [Accepted: 01/09/2024] [Indexed: 02/04/2024] Open
Abstract
COVID-19 lockdown can lead to job adaptation disorders, which are heterogeneous among individuals. The purpose of this study was to explore the association between perceived social support and job adaptation disorders among workers in China during the COVID-19 pandemic. The questionnaires of Psychological Questionnaire for Public Health Emergencies, Multidimensional Scale of Perceived Social Support, Work Attitude Scale were used for this cross-section study via an online survey. The study included 626 employees. Hierarchical regression analysis and Bootstrap method were used to investigate the mediation effect of perceived social support between the emergency and job adaptation disorders. The percentages of the 5 dimensions of depression, neurasthenia, fear, compulsion-anxiety, and hypochondria in workers were 59.7%, 56.1%, 92.3%, 42.0%, and 18.7%, respectively. Social support mediated the relationship between depression, neurasthenia, obsessive-compulsive anxiety and job adaptation disorder, accounting for 18.1%, 16.1%, and 17.5% of the total effect (ab/c), respectively. Perceived social support could alleviate COVID-19 pandemic-related depression, neurasthenia, compulsion-anxiety, and job adaptation disorder in Chinese workers. Improving their perception of social support, workers may better adapt themselves to work in the challenging of the public health emergency during COVID-19 pandemic.
Collapse
Affiliation(s)
- Yongcheng Yao
- Zhengzhou Normal University, Zhengzhou, Henan, China
- WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, UK
| | - Jie Tang
- Zhengzhou University of Technology, Zhengzhou, Henan, China
| | - Zhenzhen Li
- Zhengzhou Normal University, Zhengzhou, Henan, China
| | - Shuyan Chen
- Zhengzhou Normal University, Zhengzhou, Henan, China
| | - Yuping Li
- Zhengzhou Normal University, Zhengzhou, Henan, China
| | - Hongling Meng
- Zhengzhou Normal University, Zhengzhou, Henan, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, School of Medicine, Yale University, New Haven, Connecticut, USA
| |
Collapse
|
9
|
Abdul Halim A, Abreu P, Aglietta M, Allekotte I, Cheminant KA, Almela A, Aloisio R, Alvarez-Muñiz J, Yebra JA, Anastasi GA, Anchordoqui L, Andrada B, Andringa S, Anukriti, Apollonio L, Aramo C, Ferreira PRA, Arnone E, Velázquez JCA, Assis P, Avila G, Avocone E, Bakalova A, Barbato F, Mocellin AB, Bellido JA, Berat C, Bertaina ME, Bhatta G, Bianciotto M, Biermann PL, Binet V, Bismark K, Bister T, Biteau J, Blazek J, Bleve C, Blümer J, Boháčová M, Boncioli D, Bonifazi C, Arbeletche LB, Borodai N, Brack J, Orchera PGB, Briechle FL, Bueno A, Buitink S, Buscemi M, Büsken M, Bwembya A, Caballero-Mora KS, Cabana-Freire S, Caccianiga L, Caruso R, Castellina A, Catalani F, Cataldi G, Cazon L, Cerda M, Cermenati A, Chinellato JA, Chudoba J, Chytka L, Clay RW, Cerutti ACC, Colalillo R, Coleman A, Coluccia MR, Conceição R, Condorelli A, Consolati G, Conte M, Convenga F, Dos Santos DC, Costa PJ, Covault CE, Cristinziani M, Sanchez CSC, Dasso S, Daumiller K, Dawson BR, de Almeida RM, de Jesús J, de Jong SJ, Neto JRTDM, De Mitri I, de Oliveira J, Franco DDO, de Palma F, de Souza V, de Errico BPDS, De Vito E, Del Popolo A, Deligny O, Denner N, Deval L, di Matteo A, Dobre M, Dobrigkeit C, D'Olivo JC, Mendes LMD, Dorosti Q, Dos Anjos JC, Dos Anjos RC, Ebr J, Ellwanger F, Emam M, Engel R, Epicoco I, Erdmann M, Etchegoyen A, Evoli C, Falcke H, Farmer J, Farrar G, Fauth AC, Fazzini N, Feldbusch F, Fenu F, Fernandes A, Fick B, Figueira JM, Filipčič A, Fitoussi T, Flaggs B, Fodran T, Fujii T, Fuster A, Galea C, Galelli C, García B, Gaudu C, Gemmeke H, Gesualdi F, Gherghel-Lascu A, Ghia PL, Giaccari U, Glombitza J, Gobbi F, Gollan F, Golup G, Berisso MG, Vitale PFG, Gongora JP, González JM, González N, Goos I, Góra D, Gorgi A, Gottowik M, Grubb TD, Guarino F, Guedes GP, Guido E, Gülzow L, Hahn S, Hamal P, Hampel MR, Hansen P, Harari D, Harvey VM, Haungs A, Hebbeker T, Hojvat C, Hörandel JR, Horvath P, Hrabovský M, Huege T, Insolia A, Isar PG, Janecek P, Jilek V, Johnsen JA, Jurysek J, Kampert KH, Keilhauer B, Khakurdikar A, Covilakam VVK, Klages HO, Kleifges M, Knapp F, Köhler J, Kunka N, Lago BL, Langner N, de Oliveira MAL, Lema-Capeans Y, Letessier-Selvon A, Lhenry-Yvon I, Lopes L, Lu L, Luce Q, Lundquist JP, Payeras AM, Majercakova M, Mandat D, Manning BC, Mantsch P, Marafico S, Mariani FM, Mariazzi AG, Mariş IC, Marsella G, Martello D, Martinelli S, Bravo OM, Martins MA, Mathes HJ, Matthews J, Matthiae G, Mayotte E, Mayotte S, Mazur PO, Medina-Tanco G, Meinert J, Melo D, Menshikov A, Merx C, Michal S, Micheletti MI, Miramonti L, Mollerach S, Montanet F, Morejon L, Morello C, Mulrey K, Mussa R, Namasaka WM, Negi S, Nellen L, Nguyen K, Nicora G, Niechciol M, Nitz D, Nosek D, Novotny V, Nožka L, Nucita A, Núñez LA, Oliveira C, Palatka M, Pallotta J, Panja S, Parente G, Paulsen T, Pawlowsky J, Pech M, Pękala J, Pelayo R, Pereira LAS, Martins EEP, Armand JP, Bertolli CP, Perrone L, Petrera S, Petrucci C, Pierog T, Pimenta M, Platino M, Pont B, Pothast M, Shahvar MP, Privitera P, Prouza M, Puyleart A, Querchfeld S, Rautenberg J, Ravignani D, Akim JVR, Reininghaus M, Ridky J, Riehn F, Risse M, Rizi V, de Carvalho WR, Rodriguez E, Rojo JR, Roncoroni MJ, Rossoni S, Roth M, Roulet E, Rovero AC, Ruehl P, Saftoiu A, Saharan M, Salamida F, Salazar H, Salina G, Gomez JDS, Sánchez F, Santos EM, Santos E, Sarazin F, Sarmento R, Sato R, Savina P, Schäfer CM, Scherini V, Schieler H, Schimassek M, Schimp M, Schmidt D, Scholten O, Schoorlemmer H, Schovánek P, Schröder FG, Schulte J, Schulz T, Sciutto SJ, Scornavacche M, Segreto A, Sehgal S, Shivashankara SU, Sigl G, Silli G, Sima O, Simkova K, Simon F, Smau R, Šmída R, Sommers P, Soriano JF, Squartini R, Stadelmaier M, Stanič S, Stasielak J, Stassi P, Strähnz S, Straub M, Suomijärvi T, Supanitsky AD, Svozilikova Z, Szadkowski Z, Tairli F, Tapia A, Taricco C, Timmermans C, Tkachenko O, Tobiska P, Peixoto CJT, Tomé B, Torrès Z, Travaini A, Travnicek P, Trimarelli C, Tueros M, Unger M, Vaclavek L, Vacula M, Galicia JFV, Valore L, Varela E, Vásquez-Ramírez A, Veberič D, Ventura C, Quispe IDV, Verzi V, Vicha J, Vink J, Vorobiov S, Watanabe C, Watson AA, Weindl A, Wiencke L, Wilczyński H, Wittkowski D, Wundheiler B, Yue B, Yushkov A, Zapparrata O, Zas E, Zavrtanik D, Zavrtanik M. Demonstrating Agreement between Radio and Fluorescence Measurements of the Depth of Maximum of Extensive Air Showers at the Pierre Auger Observatory. Phys Rev Lett 2024; 132:021001. [PMID: 38277596 DOI: 10.1103/physrevlett.132.021001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 10/16/2023] [Accepted: 10/24/2023] [Indexed: 01/28/2024]
Abstract
We show, for the first time, radio measurements of the depth of shower maximum (X_{max}) of air showers induced by cosmic rays that are compared to measurements of the established fluorescence method at the same location. Using measurements at the Pierre Auger Observatory we show full compatibility between our radio and the previously published fluorescence dataset, and between a subset of air showers observed simultaneously with both radio and fluorescence techniques, a measurement setup unique to the Pierre Auger Observatory. Furthermore, we show radio X_{max} resolution as a function of energy and demonstrate the ability to make competitive high-resolution X_{max} measurements with even a sparse radio array. With this, we show that the radio technique is capable of cosmic-ray mass composition studies, both at Auger and at other experiments.
Collapse
Affiliation(s)
- A Abdul Halim
- University of Adelaide, Adelaide, South Australia, Australia
| | - P Abreu
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Aglietta
- INFN, Sezione di Torino, Torino, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
| | - I Allekotte
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | | | - A Almela
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - R Aloisio
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - J Alvarez-Muñiz
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Ammerman Yebra
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - G A Anastasi
- INFN, Sezione di Torino, Torino, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
| | - L Anchordoqui
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
| | - B Andrada
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - S Andringa
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - Anukriti
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - L Apollonio
- INFN, Sezione di Milano, Milano, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
| | - C Aramo
- INFN, Sezione di Napoli, Napoli, Italy
| | | | - E Arnone
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | | | - P Assis
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - G Avila
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - E Avocone
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - A Bakalova
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Barbato
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | | | - J A Bellido
- University of Adelaide, Adelaide, South Australia, Australia
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
| | - C Berat
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - M E Bertaina
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - G Bhatta
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - M Bianciotto
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - P L Biermann
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - V Binet
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
| | - K Bismark
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - T Bister
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - J Biteau
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - J Blazek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Bleve
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - J Blümer
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Boháčová
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - D Boncioli
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - C Bonifazi
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - N Borodai
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - J Brack
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - P G Brichetto Orchera
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - F L Briechle
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - A Bueno
- Universidad de Granada and C.A.F.P.E., Granada, Spain
| | - S Buitink
- Vrije Universiteit Brussels, Brussels, Belgium
| | - M Buscemi
- INFN, Sezione di Catania, Catania, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
| | - M Büsken
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - A Bwembya
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | | | - S Cabana-Freire
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - L Caccianiga
- INFN, Sezione di Milano, Milano, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
| | - R Caruso
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - A Castellina
- INFN, Sezione di Torino, Torino, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
| | - F Catalani
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
| | - G Cataldi
- INFN, Sezione di Lecce, Lecce, Italy
| | - L Cazon
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Cerda
- Observatorio Pierre Auger, Malargüe, Argentina
| | - A Cermenati
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - J A Chinellato
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - J Chudoba
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - L Chytka
- Palacky University, Olomouc, Czech Republic
| | - R W Clay
- University of Adelaide, Adelaide, South Australia, Australia
| | - A C Cobos Cerutti
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - R Colalillo
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
| | - A Coleman
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
| | | | - R Conceição
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - A Condorelli
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - G Consolati
- INFN, Sezione di Milano, Milano, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
| | - M Conte
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - F Convenga
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | | | - P J Costa
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - C E Covault
- Case Western Reserve University, Cleveland, Ohio, USA
| | - M Cristinziani
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - C S Cruz Sanchez
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - S Dasso
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
| | - K Daumiller
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - B R Dawson
- University of Adelaide, Adelaide, South Australia, Australia
| | - R M de Almeida
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
| | - J de Jesús
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - S J de Jong
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - J R T de Mello Neto
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
| | - I De Mitri
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - J de Oliveira
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
| | | | - F de Palma
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - V de Souza
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
| | - B P de Souza de Errico
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
| | - E De Vito
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - A Del Popolo
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - O Deligny
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - N Denner
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - L Deval
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | | | - M Dobre
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - C Dobrigkeit
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - J C D'Olivo
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - L M Domingues Mendes
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - Q Dorosti
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - J C Dos Anjos
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
| | - R C Dos Anjos
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
| | - J Ebr
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Ellwanger
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Emam
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - R Engel
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - I Epicoco
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - M Erdmann
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - A Etchegoyen
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - C Evoli
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - H Falcke
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
| | - J Farmer
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - G Farrar
- New York University, New York, New York, USA
| | - A C Fauth
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - N Fazzini
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - F Feldbusch
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Fenu
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Fernandes
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - B Fick
- Michigan Technological University, Houghton, Michigan, USA
| | - J M Figueira
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Filipčič
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
| | - T Fitoussi
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - B Flaggs
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
| | - T Fodran
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - T Fujii
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - A Fuster
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
| | - C Galea
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - C Galelli
- INFN, Sezione di Milano, Milano, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
| | - B García
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
| | - C Gaudu
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - H Gemmeke
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Gesualdi
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Gherghel-Lascu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - P L Ghia
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | | | - J Glombitza
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - F Gobbi
- Observatorio Pierre Auger, Malargüe, Argentina
| | - F Gollan
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - G Golup
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - M Gómez Berisso
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - P F Gómez Vitale
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - J P Gongora
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - J M González
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - N González
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - I Goos
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - D Góra
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - A Gorgi
- INFN, Sezione di Torino, Torino, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
| | - M Gottowik
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - T D Grubb
- University of Adelaide, Adelaide, South Australia, Australia
| | - F Guarino
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
| | - G P Guedes
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
| | - E Guido
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - L Gülzow
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - S Hahn
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - P Hamal
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - M R Hampel
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - P Hansen
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - D Harari
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - V M Harvey
- University of Adelaide, Adelaide, South Australia, Australia
| | - A Haungs
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - T Hebbeker
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - C Hojvat
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - J R Hörandel
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - P Horvath
- Palacky University, Olomouc, Czech Republic
| | | | - T Huege
- Vrije Universiteit Brussels, Brussels, Belgium
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Insolia
- INFN, Sezione di Catania, Catania, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
| | - P G Isar
- Institute of Space Science, Bucharest-Magurele, Romania
| | - P Janecek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - V Jilek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J A Johnsen
- Colorado School of Mines, Golden, Colorado, USA
| | - J Jurysek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - K-H Kampert
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - B Keilhauer
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Khakurdikar
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - V V Kizakke Covilakam
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - H O Klages
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Kleifges
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - F Knapp
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - J Köhler
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - N Kunka
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - B L Lago
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
| | - N Langner
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | | | - Y Lema-Capeans
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - A Letessier-Selvon
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
| | - I Lhenry-Yvon
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - L Lopes
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - L Lu
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - Q Luce
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - J P Lundquist
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - A Machado Payeras
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
| | - M Majercakova
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - D Mandat
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - B C Manning
- University of Adelaide, Adelaide, South Australia, Australia
| | - P Mantsch
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - S Marafico
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - F M Mariani
- INFN, Sezione di Milano, Milano, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
| | - A G Mariazzi
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - I C Mariş
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - G Marsella
- INFN, Sezione di Catania, Catania, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
| | - D Martello
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - S Martinelli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | | | - M A Martins
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - H-J Mathes
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - J Matthews
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - G Matthiae
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
| | - E Mayotte
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Colorado School of Mines, Golden, Colorado, USA
| | - S Mayotte
- Colorado School of Mines, Golden, Colorado, USA
| | - P O Mazur
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - G Medina-Tanco
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - J Meinert
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - D Melo
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - A Menshikov
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - C Merx
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - S Michal
- Palacky University, Olomouc, Czech Republic
| | - M I Micheletti
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
| | - L Miramonti
- INFN, Sezione di Milano, Milano, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
| | - S Mollerach
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - F Montanet
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - L Morejon
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - C Morello
- INFN, Sezione di Torino, Torino, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
| | - K Mulrey
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - R Mussa
- INFN, Sezione di Torino, Torino, Italy
| | - W M Namasaka
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - S Negi
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - L Nellen
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - K Nguyen
- Michigan Technological University, Houghton, Michigan, USA
| | - G Nicora
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
| | - M Niechciol
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - D Nitz
- Michigan Technological University, Houghton, Michigan, USA
| | - D Nosek
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - V Novotny
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - L Nožka
- Palacky University, Olomouc, Czech Republic
| | - A Nucita
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - L A Núñez
- Universidad Industrial de Santander, Bucaramanga, Colombia
| | - C Oliveira
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
| | - M Palatka
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Pallotta
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
| | - S Panja
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - G Parente
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - T Paulsen
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - J Pawlowsky
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - M Pech
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Pękala
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - R Pelayo
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
| | - L A S Pereira
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
| | - E E Pereira Martins
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - J Perez Armand
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
| | - C Pérez Bertolli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - L Perrone
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - S Petrera
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
| | - C Petrucci
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - T Pierog
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Pimenta
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - M Platino
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - B Pont
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - M Pothast
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - M Pourmohammad Shahvar
- INFN, Sezione di Catania, Catania, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
| | - P Privitera
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - M Prouza
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - A Puyleart
- Michigan Technological University, Houghton, Michigan, USA
| | - S Querchfeld
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - J Rautenberg
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - D Ravignani
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | | | - M Reininghaus
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - J Ridky
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Riehn
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - M Risse
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - V Rizi
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | | | - E Rodriguez
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - J Rodriguez Rojo
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - M J Roncoroni
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - S Rossoni
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - M Roth
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - E Roulet
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
| | - A C Rovero
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
| | - P Ruehl
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
| | - A Saftoiu
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - M Saharan
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
| | - F Salamida
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - H Salazar
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | - G Salina
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | | | - F Sánchez
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - E M Santos
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
| | - E Santos
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F Sarazin
- Colorado School of Mines, Golden, Colorado, USA
| | - R Sarmento
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - R Sato
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
| | - P Savina
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - C M Schäfer
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - V Scherini
- INFN, Sezione di Lecce, Lecce, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
| | - H Schieler
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - M Schimassek
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
| | - M Schimp
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - D Schmidt
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - O Scholten
- Vrije Universiteit Brussels, Brussels, Belgium
| | - H Schoorlemmer
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - P Schovánek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - F G Schröder
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
| | - J Schulte
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - T Schulz
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - S J Sciutto
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - M Scornavacche
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - A Segreto
- INFN, Sezione di Catania, Catania, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
| | - S Sehgal
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - S U Shivashankara
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - G Sigl
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
| | - G Silli
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - O Sima
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - K Simkova
- Vrije Universiteit Brussels, Brussels, Belgium
| | - F Simon
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
| | - R Smau
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
| | - R Šmída
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
| | - P Sommers
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - J F Soriano
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
| | - R Squartini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - M Stadelmaier
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- INFN, Sezione di Milano, Milano, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
| | - S Stanič
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - J Stasielak
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - P Stassi
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - S Strähnz
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
| | - M Straub
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
| | - T Suomijärvi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
| | - A D Supanitsky
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - Z Svozilikova
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - Z Szadkowski
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
| | - F Tairli
- University of Adelaide, Adelaide, South Australia, Australia
| | - A Tapia
- Universidad de Medellín, Medellín, Colombia
| | - C Taricco
- INFN, Sezione di Torino, Torino, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
| | - C Timmermans
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
| | - O Tkachenko
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - P Tobiska
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C J Todero Peixoto
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
| | - B Tomé
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
| | - Z Torrès
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
| | - A Travaini
- Observatorio Pierre Auger, Malargüe, Argentina
| | - P Travnicek
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Trimarelli
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
| | - M Tueros
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
| | - M Unger
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - L Vaclavek
- Palacky University, Olomouc, Czech Republic
| | - M Vacula
- Palacky University, Olomouc, Czech Republic
| | - J F Valdés Galicia
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
| | - L Valore
- INFN, Sezione di Napoli, Napoli, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
| | - E Varela
- Benemérita Universidad Autónoma de Puebla, Puebla, México
| | | | - D Veberič
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - C Ventura
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - V Verzi
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
| | - J Vicha
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Vink
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
| | - S Vorobiov
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
| | - C Watanabe
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
| | - A A Watson
- Centro Atómico Bariloche and Instituto Balseiro (CNEA-UNCuyo-CONICET), San Carlos de Bariloche, Argentina
- Departamento de Física and Departamento de Ciencias de la Atmósfera y los Océanos, FCEyN, Universidad de Buenos Aires and CONICET, Buenos Aires, Argentina
- IFLP, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
- Instituto de Astronomía y Física del Espacio (IAFE, CONICET-UBA), Buenos Aires, Argentina
- Instituto de Física de Rosario (IFIR)-CONICET/U.N.R. and Facultad de Ciencias Bioquímicas y Farmacéuticas U.N.R., Rosario, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), and Universidad Tecnológica Nacional-Facultad Regional Mendoza (CONICET/CNEA), Mendoza, Argentina
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
- International Center of Advanced Studies and Instituto de Ciencias Físicas, ECyT-UNSAM and CONICET, Campus Miguelete-San Martín, Buenos Aires, Argentina
- Laboratorio Atmósfera-Departamento de Investigaciones en Láseres y sus Aplicaciones-UNIDEF (CITEDEF-CONICET), Argentina
- Observatorio Pierre Auger, Malargüe, Argentina
- Observatorio Pierre Auger and Comisión Nacional de Energía Atómica, Malargüe, Argentina
- Universidad Tecnológica Nacional-Facultad Regional Buenos Aires, Buenos Aires, Argentina
- University of Adelaide, Adelaide, South Australia, Australia
- Université Libre de Bruxelles (ULB), Brussels, Belgium
- Vrije Universiteit Brussels, Brussels, Belgium
- Centro Brasileiro de Pesquisas Fisicas, Rio de Janeiro, Rio de Janeiro, Brazil
- Centro Federal de Educação Tecnológica Celso Suckow da Fonseca, Petropolis, Brazil
- Instituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro (IFRJ), Brazil
- Universidade de São Paulo, Escola de Engenharia de Lorena, Lorena, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física de São Carlos, São Carlos, São Paulo, Brazil
- Universidade de São Paulo, Instituto de Física, São Paulo, São Paulo, Brazil
- Universidade Estadual de Campinas, IFGW, Campinas, São Paulo, Brazil
- Universidade Estadual de Feira de Santana, Feira de Santana, Brazil
- Universidade Federal de Campina Grande, Centro de Ciencias e Tecnologia, Campina Grande, Brazil
- Universidade Federal do ABC, Santo André, São Paulo, Brazil
- Universidade Federal do Paraná, Setor Palotina, Palotina, Brazil
- Universidade Federal do Rio de Janeiro, Instituto de Física, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal do Rio de Janeiro (UFRJ), Observatório do Valongo, Rio de Janeiro, Rio de Janeiro, Brazil
- Universidade Federal Fluminense, EEIMVR, Volta Redonda, Rio de Janeiro, Brazil
- Universidad de Medellín, Medellín, Colombia
- Universidad Industrial de Santander, Bucaramanga, Colombia
- Charles University, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
- Palacky University, Olomouc, Czech Republic
- CNRS/IN2P3, IJCLab, Université Paris-Saclay, Orsay, France
- Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Sorbonne Université, Université de Paris, CNRS-IN2P3, Paris, France
- Université Grenoble Alpes, CNRS, Grenoble Institute of Engineering Université Grenoble Alpes, LPSC-IN2P3, 38000 Grenoble, France
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Experimental Particle Physics, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institut für Prozessdatenverarbeitung und Elektronik, Karlsruhe, Germany
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
- RWTH Aachen University, III. Physikalisches Institut A, Aachen, Germany
- Universität Hamburg, II. Institut für Theoretische Physik, Hamburg, Germany
- Universität Siegen, Department Physik-Experimentelle Teilchenphysik, Siegen, Germany
- Gran Sasso Science Institute, L'Aquila, Italy
- INFN Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila), Italy
- INFN, Sezione di Catania, Catania, Italy
- INFN, Sezione di Lecce, Lecce, Italy
- INFN, Sezione di Milano, Milano, Italy
- INFN, Sezione di Napoli, Napoli, Italy
- INFN, Sezione di Roma "Tor Vergata," Roma, Italy
- INFN, Sezione di Torino, Torino, Italy
- Istituto di Astrofisica Spaziale e Fisica Cosmica di Palermo (INAF), Palermo, Italy
- Osservatorio Astrofisico di Torino (INAF), Torino, Italy
- Politecnico di Milano, Dipartimento di Scienze e Tecnologie Aerospaziali, Milano, Italy
- Università del Salento, Dipartimento di Matematica e Fisica "E. De Giorgi," Lecce, Italy
- Università dell'Aquila, Dipartimento di Scienze Fisiche e Chimiche, L'Aquila, Italy
- Università di Catania, Dipartimento di Fisica e Astronomia "Ettore Majorana," Catania, Italy
- Università di Milano, Dipartimento di Fisica, Milano, Italy
- Università di Napoli "Federico II," Dipartimento di Fisica "Ettore Pancini," Napoli, Italy
- Università di Palermo, Dipartimento di Fisica e Chimica "E. Segrè," Palermo, Italy
- Università di Roma "Tor Vergata," Dipartimento di Fisica, Roma, Italy
- Università Torino, Dipartimento di Fisica, Torino, Italy
- Benemérita Universidad Autónoma de Puebla, Puebla, México
- Unidad Profesional Interdisciplinaria en Ingeniería y Tecnologías Avanzadas del Instituto Politécnico Nacional (UPIITA-IPN), México, Distrito Federal, México
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, México
- Universidad Nacional Autónoma de México, México, Distrito Federal, México
- Universidad Nacional de San Agustin de Arequipa, Facultad de Ciencias Naturales y Formales, Arequipa, Peru
- Institute of Nuclear Physics PAN, Krakow, Poland
- University of Łódź, Faculty of High-Energy Astrophysics,Łódź, Poland
- Laboratório de Instrumentação e Física Experimental de Partículas-LIP and Instituto Superior Técnico-IST, Universidade de Lisboa-UL, Lisboa, Portugal
- "Horia Hulubei" National Institute for Physics and Nuclear Engineering, Bucharest-Magurele, Romania
- Institute of Space Science, Bucharest-Magurele, Romania
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
- Universidad de Granada and C.A.F.P.E., Granada, Spain
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- IMAPP, Radboud University Nijmegen, Nijmegen, The Netherlands
- Nationaal Instituut voor Kernfysica en Hoge Energie Fysica (NIKHEF), Science Park, Amsterdam, The Netherlands
- Stichting Astronomisch Onderzoek in Nederland (ASTRON), Dwingeloo, The Netherlands
- Universiteit van Amsterdam, Faculty of Science, Amsterdam, The Netherlands
- Case Western Reserve University, Cleveland, Ohio, USA
- Colorado School of Mines, Golden, Colorado, USA
- Department of Physics and Astronomy, Lehman College, City University of New York, Bronx, New York, USA
- Michigan Technological University, Houghton, Michigan, USA
- New York University, New York, New York, USA
- University of Chicago, Enrico Fermi Institute, Chicago, Illinois, USA
- University of Delaware, Department of Physics and Astronomy, Bartol Research Institute, Newark, Delaware, USA
- University of Wisconsin-Madison, Department of Physics and WIPAC, Madison, Wisconsin, USA
| | - A Weindl
- Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics, Karlsruhe, Germany
| | - L Wiencke
- Colorado School of Mines, Golden, Colorado, USA
| | - H Wilczyński
- Institute of Nuclear Physics PAN, Krakow, Poland
| | - D Wittkowski
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - B Wundheiler
- Instituto de Tecnologías en Detección y Astropartículas (CNEA, CONICET, UNSAM), Buenos Aires, Argentina
| | - B Yue
- Bergische Universität Wuppertal, Department of Physics, Wuppertal, Germany
| | - A Yushkov
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - O Zapparrata
- Université Libre de Bruxelles (ULB), Brussels, Belgium
| | - E Zas
- Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - D Zavrtanik
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
| | - M Zavrtanik
- Center for Astrophysics and Cosmology (CAC), University of Nova Gorica, Nova Gorica, Slovenia
- Experimental Particle Physics Department, J. Stefan Institute, Ljubljana, Slovenia
| |
Collapse
|
10
|
Li N, Yao S, Yu G, Lu L, Wang Z. tRFtarget 2.0: expanding the targetome landscape of transfer RNA-derived fragments. Nucleic Acids Res 2024; 52:D345-D350. [PMID: 37811890 PMCID: PMC10767876 DOI: 10.1093/nar/gkad815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2023] [Revised: 08/22/2023] [Accepted: 09/20/2023] [Indexed: 10/10/2023] Open
Abstract
tRFtarget 1.0 (http://trftarget.net/) is a platform consolidating both computationally predicted and experimentally validated binding sites between transfer RNA-derived fragments (tRFs) and target genes (or transcripts) across multiple organisms. Here, we introduce a newly released version of tRFtarget 2.0, in which we integrated 6 additional tRF sources, resulting in a comprehensive collection of 2614 high-quality tRF sequences spanning across 9 species, including 1944 Homo sapiens tRFs and one newly incorporated species Rattus norvegicus. We also expanded target genes by including ribosomal RNAs, long non-coding RNAs, and coding genes >50 kb in length. The predicted binding sites have surged up to approximately 6 billion, a 20.5-fold increase than that in tRFtarget 1.0. The manually curated publications relevant to tRF targets have increased to 400 and the gene-level experimental evidence has risen to 232. tRFtarget 2.0 introduces several new features, including a web-based tool that identifies potential binding sites of tRFs in user's own datasets, integration of standardized tRF IDs, and inclusion of external links to contents within the database. Additionally, we enhanced website framework and user interface. With these improvements, tRFtarget 2.0 is more user-friendly, providing researchers a streamlined and comprehensive platform to accelerate their research progress.
Collapse
Affiliation(s)
- Ningshan Li
- The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, China
- School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China
| | - Siqiong Yao
- Joint International Research Laboratory of Metabolic & Developmental Sciences, Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
- SJTU-Yale Joint Center of Biostatistics and Data Science, National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China
| | - Guangjun Yu
- The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 06520, USA
| | - Zuoheng Wang
- Department of Biostatistics, Yale School of Public Health, New Haven, CT 06520, USA
| |
Collapse
|
11
|
Botella R, Cao W, Celis J, Fernández-Catalá J, Greco R, Lu L, Pankratova V, Temerov F. Activating two-dimensional semiconductors for photocatalysis: a cross-dimensional strategy. J Phys Condens Matter 2024; 36:141501. [PMID: 38086082 DOI: 10.1088/1361-648x/ad14c8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Accepted: 12/12/2023] [Indexed: 01/05/2024]
Abstract
The emerging two-dimensional (2D) semiconductors substantially extend materials bases for versatile applications such as semiconductor photocatalysis demanding semiconductive matrices and large surface areas. The dimensionality, while endowing 2D semiconductors the unique properties to host photocatalytic functionality of pollutant removal and hydrogen evolution, hurdles the activation paths to form heterogenous photocatalysts where the photochemical processes are normally superior over these on the mono-compositional counterparts. In this perspective, we present a cross-dimensional strategy to employ thenD (n= 0-2) clusters or nanomaterials as activation partners to boost the photocatalytic activities of the 2D semiconductors. The formation principles of heterogenous photocatalysts are illustrated specifically for the 2D matrices, followed by selection criteria of them among the vast 2D database. The computer investigations are illustrated in the density functional theory route and machine learning benefitted from the vast samples in the 2D library. Synthetic realizations and characterizations of the 2D heterogenous systems are introduced with an emphasis on chemical methods and advanced techniques to understand materials and mechanistic studies. The perspective outlooks cross-dimensional activation strategies of the 2D materials for other applications such as CO2removal, and materials matrices in other dimensions which may inspire incoming research within these fields.
Collapse
Affiliation(s)
- R Botella
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| | - W Cao
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| | - J Celis
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| | - J Fernández-Catalá
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| | - R Greco
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| | - L Lu
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| | - V Pankratova
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| | - F Temerov
- Nano and Molecular Systems Research Unit, Faculty of Science, University of Oulu, Oulu, FIN-90014, Finland
| |
Collapse
|
12
|
Han R, Wang Y, Lu L. Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment. Pharmaceutics 2023; 16:59. [PMID: 38258070 PMCID: PMC10821464 DOI: 10.3390/pharmaceutics16010059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2023] [Revised: 12/21/2023] [Accepted: 12/25/2023] [Indexed: 01/24/2024] Open
Abstract
This study builds upon the groundbreaking mRNA vaccine Nobel Prize win in 2023 for COVID-19 prevention, paving the way for next-generation mRNA cancer vaccines to revolutionize immunotherapy. Despite the existing challenges, such as the presence of a suppressive tumor microenvironment and the identification of cancer-associated antigens, recent results from the KEYNOTE-942 trial have successfully demonstrated the effectiveness of mRNA-based cancer treatments, providing clinical evidence for the first time. This trial aimed to evaluate the efficacy and safety of combining immune checkpoint inhibitors with mRNA-based therapies in treating cancer. This advancement undeniably represents new hope for hepatocellular carcinoma (HCC) patients. However, progress in this field remains limited. In this article, we summarized the current state of applying immune checkpoint inhibitors (ICIs) combined with neoantigen mRNA vaccines. Additionally, we discussed potential targets for designing novel mRNA vaccines and potential mRNA vaccine delivery vehicles. The objective of this article is to inspire enthusiasm for the exploration of innovative therapeutic strategies that combine ICIs with neoantigen mRNA vaccines for HCC treatment and HCC prevention.
Collapse
Affiliation(s)
- Rui Han
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
- Department of Chinese Medicine, Naval Medical University, Shanghai 200433, China
- Department of Oncology, The First Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangzhou 510405, China
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
| | - Yuqian Wang
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
- Department of Chinese Medicine, Naval Medical University, Shanghai 200433, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
- School of Medicine, Center for Biomedical Data Science, New Haven, CT 06520-8034, USA
- Yale Cancer Center, Yale University, New Haven, CT 06520-8034, USA
| |
Collapse
|
13
|
Lu L. [Progress in pathophysiology research and update on diagnosis and treatment strategies for fecal incontinence]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:1126-1131. [PMID: 38110273 DOI: 10.3760/cma.j.cn441530-20231008-00122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 12/20/2023]
Abstract
The traditional barrier theory believes that fecal incontinence is related to an imbalance of the recto-anal barrier and the characteristics of stool. However, in clinical practice this theory proves unable to explain all types of fecal incontinence. In recent years, research on the mechanisms related to fecal incontinence has shifted to a new integrative concept with the rectum and anus as functional units, and the central-peripheral nervous system and internal and external anal sphincters as a control loop. The diagnosis and treatment strategy of fecal incontinence, which is replaced by sacral neuromodulation, is undergoing a quiet change. With the progressively aging population in China, the need to improve the diagnosis and treatment of fecal incontinence has become increasingly urgent. This article explores the trends in diagnosis and treatment and mechanism research from the perspective of recent advances in pathophysiological research and updated diagnosis and treatment methods for fecal incontinence.
Collapse
Affiliation(s)
- L Lu
- Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China
| |
Collapse
|
14
|
Zheng J, Sun B, Berardi D, Lu L, Yan H, Zheng S, Aladelokun O, Xie Y, Cai Y, Godri Pollitt KJ, Khan SA, Johnson CH. Perfluorooctanesulfonic Acid and Perfluorooctanoic Acid Promote Migration of Three-Dimensional Colorectal Cancer Spheroids. Environ Sci Technol 2023; 57:21016-21028. [PMID: 38064429 DOI: 10.1021/acs.est.3c04844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/20/2023]
Abstract
Perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) are persistent environmental contaminants that are of increasing public concern worldwide. However, their relationship with colorectal cancer (CRC) is poorly understood. This study aims to comprehensively investigate the effect of PFOS and PFOA on the development and progression of CRC in vitro using a series of biological techniques and metabolic profiling. Herein, the migration of three-dimensional (3D) spheroids of two CRC cell lines, SW48 KRAS wide-type (WT) and SW48 KRAS G12A, were observed after exposure to PFOS and PFOA at 2 μM and 10 μM for 7 days. The time and dose-dependent migration phenotype induced by 10 μM PFOS and PFOA was further confirmed by wound healing and trans-well migration assays. To investigate the mechanism of action, derivatization-mass spectrometry-based metabolic profiles were examined from 3D spheroids of SW48 cell lines exposed to PFOS and PFOA (2 μM and 10 μM). Our findings revealed this exposure altered epithelial-mesenchymal transition related metabolic pathways, including fatty acid β-oxidation and synthesis of proteins, nucleotides, and lipids. Furthermore, this phenotype was confirmed by the downregulation of E-cadherin and upregulation of N-cadherin and vimentin. These findings show novel insight into the relationship between PFOS, PFOA, and CRC.
Collapse
Affiliation(s)
- Jie Zheng
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut 06510, United States
| | - Boshi Sun
- Division of Surgical Oncology, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510, United States
- Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China
| | - Domenica Berardi
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut 06510, United States
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, Connecticut 06510, United States
| | - Hong Yan
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut 06510, United States
| | - Shujian Zheng
- Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, United States
| | - Oladimeji Aladelokun
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut 06510, United States
| | - Yangzhouyun Xie
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510, United States
| | - Yujun Cai
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510, United States
| | - Krystal J Godri Pollitt
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut 06510, United States
| | - Sajid A Khan
- Division of Surgical Oncology, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510, United States
| | - Caroline H Johnson
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, Connecticut 06510, United States
| |
Collapse
|
15
|
Deneuve S, Fervers B, Senkin S, Bouaoun L, Pérol O, Chavanel B, Lu L, Coste I, Renno T, Zavadil J, Virard F. Molecular landscapes of oral cancers of unknown etiology. medRxiv 2023:2023.12.15.23299866. [PMID: 38168303 PMCID: PMC10760302 DOI: 10.1101/2023.12.15.23299866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2024]
Abstract
The incidence of the mobile tongue cancer in young patients has been rising. This oral cancer (OC) type has no identified risk factors (NIRF), no established molecular markers and is not yet recognized as a distinct clinical entity. To understand this emerging malignancy, we innovatively analyzed the public head and neck cancer multi-omics data. We identified mutational signatures that successfully stratified 307 OC and 109 laryngeal cancer cases according to their clinico-pathological characteristics. The NIRF OCs exhibited significantly increased activities of endogenous clock-like and APOBEC-associated mutagenesis, alongside specific cancer driver gene mutations, distinct methylome patterns and prominent antimicrobial transcriptomic responses. Furthermore, we show that mutational signature SBS16 in OCs reflects the combined effects of alcohol drinking and tobacco smoking. Our study characterizes the unique disease histories and molecular programs of the NIRF OCs revealing that this emerging cancer subtype is likely driven by increased endogenous mutagenesis correlated with responses to microbial insults.
Collapse
|
16
|
Zhao D, Suo LD, Pan JB, Peng XH, Wang YF, Zhou T, Li XM, Ma Y, Li ZA, Pang XH, Lu L. [A follow-up study on the pain changes trend and effects in patients diagnosed with herpes zoster in Beijing City]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:2068-2072. [PMID: 38186158 DOI: 10.3760/cma.j.cn112150-20230607-00447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2024]
Abstract
Objective: To understand the changes in pain and its effects in patients with the diagnosis of herpes zoster. Methods: A total of 3 487 patients diagnosed with herpes zoster (HZ) for the first time at the outpatient department of Miyun District Hospital from January 1, 2017, to December 31, 2019, were included in the study. The information of patients was registered and issued with a record card. Patients were required to record the time of pain and rash by themselves. Telephone follow-up was conducted at 21, 90, 180 and 365 days after the onset of rashes, including hospitalization, location of rash and pain, and the time of start and end. The impact of pain on life was evaluated by the Zoster Brief Pain Inventory (ZBPI). Results: The age of 2 999 HZ patients included in the analysis were (53±16) years old, including 1 377 (45.91%) males and 1 903 (63.45%) patients aged 50 years and older. After 21 days of rash, mild, moderate and severe pain accounted for 20.87% (626 cases), 37.98% (1 139 cases) and 33.81% (1 014 cases), respectively. Only 5.07% (152 cases) had no pain or discomfort, and 2.27% (68 cases) had no pain but discomfort. Most of the pain sites were consistent with the rash sites. The chest and back and waist and abdomen were the most common, accounting for 35.58% (1 067 cases) and 29.18% (875 cases), respectively, followed by the limbs and face and neck, accounting for 16.74% (502 cases) and 16.40% (492 cases), respectively. The M (Q1, Q3) of pain days in the HZ patients was 14 (8, 20) days, and the incidence of post-herpetic neuralgia (PHN) was 6.63% (171/2 580) (excluding 419 patients who refused to visit or lost to visit on 90 days after the onset of rash). The pain score of HZ patients within 21 days after the rash was (5.19±2.73) points, and the pain score of PHN patients was (7.61±2.13) points, which was significantly higher than that of non-PHN patients [(5.04±2.69) points] (P<0.001). Daily activities, emotions, walking ability, work, social interaction, sleep and recreation were affected for 21 days after the rash in HZ patients, ranging from 60.79% to 83.83%, with sleep being the most affected (83.83%). The impact scores of pain and life dimensions in PHN patients ranged from 4.59 to 7.61 points on the ZBPI scale, which were higher than those in non-PHN patients (2.49-5.04) (t values ranged from 8.86 to 11.67, all P values <0.001). Conclusion: The proportion of pain in HZ patients after the diagnosis is high, and the pain is more obvious in patients with PHN and HZ patients aged 50 and older, which has a greater impact on their daily lives.
Collapse
Affiliation(s)
- D Zhao
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - L D Suo
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - J B Pan
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - X H Peng
- Miyun District Center for Disease Control and Prevention, Beijing 101500, China
| | - Y F Wang
- Miyun District Center for Disease Control and Prevention, Beijing 101500, China
| | - T Zhou
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - X M Li
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - Y Ma
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - Z A Li
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - X H Pang
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - L Lu
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| |
Collapse
|
17
|
Frias-Gomez J, Alemany L, Benavente Y, Clarke MA, de Francisco J, De Vivo I, Du M, Goodman MT, Lacey J, Liao LM, Lipworth L, Lu L, Merritt MA, Michels KA, O'Connell K, Paytubi S, Pelegrina B, Peremiquel-Trillas P, Petruzella S, Ponce J, Risch H, Setiawan VW, Schouten LJ, Shu XO, Trabert B, Van den Brandt PA, Wentzensen N, Wilkens LR, Yu H, Costas L. Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Sleep Med Rev 2023; 72:101848. [PMID: 37716022 PMCID: PMC10840870 DOI: 10.1016/j.smrv.2023.101848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 09/04/2023] [Accepted: 09/05/2023] [Indexed: 09/18/2023]
Abstract
Data on the role of circadian related factors in the etiology of endometrial cancer are scarce. We collected individual data on night shift work or daily sleep duration from 7,207 cases and 22,027 controls participating in 11 studies from the Epidemiology of Endometrial Cancer Consortium (E2C2). Main analyses were performed among postmenopausal women: 6,335 endometrial cancer cases and 18,453 controls. Using individual data, study-specific odd ratios (ORs) and their corresponding 95% confidence intervals (CIs) were estimated with logistic regression and pooled analyses were conducted using random-effects meta-analyses. A non-significant inverse association was observed between endometrial cancer and night shift work (OR=0.89, 95%CI=0.72-1.09; I2=0.0%, Pheterogeneity=0.676). Associations did not vary by shift type (permanent or rotating), or duration of night work. Categorizations of short (<7h) or long (≥9h) sleep duration were not associated with endometrial cancer risk (ORshort=1.02, 95%CI=0.95-1.10; I2=55.3%, Pheterogeneity=0.022; ORlong=0.93, 95%CI=0.81-1.06; I2=11.5%, Pheterogeneity=0.339). No associations were observed per 1-h increment of sleep (OR=0.98, 95%CI=0.95-1.01; I2=46.1%, Pheterogeneity=0.063), but an inverse association was identified among obese women (OR=0.93, 95%CI=0.89-0.98 per 1-h increment; I2=12.7%, Pheterogeneity=0.329). Overall, these pooled analyses provide evidence that night shift work and sleep duration are not strong risk factors for endometrial cancer in postmenopausal women.
Collapse
Affiliation(s)
- Jon Frias-Gomez
- Cancer Epidemiology Research Programme. IDIBELL. Catalan Institute of Oncology. Hospitalet de Llobregat, Barcelona, Spain; University of Barcelona (UB), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - Laia Alemany
- Cancer Epidemiology Research Programme. IDIBELL. Catalan Institute of Oncology. Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - Yolanda Benavente
- Cancer Epidemiology Research Programme. IDIBELL. Catalan Institute of Oncology. Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - Megan A Clarke
- Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Rockville, MD, USA
| | - Javier de Francisco
- Department of Anesthesiology. Hospital Universitari de Bellvitge, IDIBELL. Hospitalet de Llobregat, Barcelona, Spain
| | - Immaculata De Vivo
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA
| | - Mengmeng Du
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Marc T Goodman
- Cedars-Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - James Lacey
- Division of Health Analytics, Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope National Medical Center, Duarte, CA, USA
| | - Linda M Liao
- Division of Cancer Epidemiology and Genetics, Metabolic Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA
| | - Loren Lipworth
- Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Lingeng Lu
- Chronic Disease Epidemiology Department, Yale School of Public Health, Yale University, New Haven, CT 06510, USA
| | - Melissa A Merritt
- The Daffodil Centre, The University of Sydney, Joint Venture with Cancer Council NSW, Sydney, NSW, Australia; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia
| | - Kara A Michels
- Division of Cancer Epidemiology and Genetics, Metabolic Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Kelli O'Connell
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Sonia Paytubi
- Cancer Epidemiology Research Programme. IDIBELL. Catalan Institute of Oncology. Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - Beatriz Pelegrina
- Cancer Epidemiology Research Programme. IDIBELL. Catalan Institute of Oncology. Hospitalet de Llobregat, Barcelona, Spain
| | - Paula Peremiquel-Trillas
- Cancer Epidemiology Research Programme. IDIBELL. Catalan Institute of Oncology. Hospitalet de Llobregat, Barcelona, Spain; University of Barcelona (UB), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - Stacey Petruzella
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Jordi Ponce
- Department of Gynecology, Hospital Universitari de Bellvitge, IDIBELL. Hospitalet de Llobregat, Barcelona, Spain
| | - Harvey Risch
- Chronic Disease Epidemiology Department, Yale School of Public Health, Yale University, New Haven, CT 06510, USA
| | - Veronica Wendy Setiawan
- Department of Preventive Medicine and Norris Comprehensive Cancer Center, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA
| | - Leo J Schouten
- Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, the Netherlands
| | - Xiao-Ou Shu
- Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Britton Trabert
- Department of Obstetrics and Gynecology, University of Utah, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA
| | - Piet A Van den Brandt
- Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, the Netherlands
| | - Nicolas Wentzensen
- Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Rockville, MD, USA
| | - Lynne R Wilkens
- Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
| | - Herbert Yu
- Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
| | - Laura Costas
- Cancer Epidemiology Research Programme. IDIBELL. Catalan Institute of Oncology. Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
| |
Collapse
|
18
|
Yan YJ, Zhang ZX, Wang X, Lu L, Zhao ZC, Li C, Liu J, Li WD, Liu T, Fu WH. [Short-term outcomes after robotic proximal gastrectomy with double-tract reconstruction]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:1071-1074. [PMID: 37974353 DOI: 10.3760/cma.j.cn441530-20230511-00164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
|
19
|
Gómez-Pascual A, Glikman DM, Ng HX, Tomkins JE, Lu L, Xu Y, Ashbrook DG, Kaczorowski C, Kempermann G, Killmar J, Mozhui K, Aebersold R, Williams EG, Williams RW, Overall RW, Jucker M, de Bakker DEM. Polyglucosan body density in the aged mouse hippocampus is controlled by a novel modifier locus on chromosome 1. bioRxiv 2023:2023.11.22.567373. [PMID: 38045339 PMCID: PMC10690248 DOI: 10.1101/2023.11.22.567373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/05/2023]
Abstract
Aging can be associated with the accumulation of hypobranched glycogen molecules (polyglucosan bodies, PGBs), particularly in astrocytes of the hippocampus. While PGBs have a detrimental effect on cognition in diseases such as adult polyglucosan body disease and Lafora disease, the underlying mechanism and clinical relevance of age-related PGB accumulation remains unknown. Here, we have investigated the genetic basis and functional impact of age-related PGB accumulation in 32 fully sequenced BXD-type strains of mice which exhibit a 400-fold variation in PGB burden in 16-18 month old females. We mapped a major locus controlling PGB density in the hippocampus to chromosome 1 at 72-75 Mb (linkage of 4.9 -logP), which we defined as the Pgb1 locus. To identify potentially causal gene variants within Pgb1, we generated extensive hippocampal transcriptome datasets and identified two strong candidate genes for which mRNA correlates with PGB density-Smarcal1 and Usp37. In addition, both Smarcal1 and Usp37 contain non-synonymous allele variations likely to impact protein function. A phenome-wide association analysis highlighted a trans-regulatory effect of the Pgb1 locus on expression of Hp1bp3, a gene known to play a role in age-related changes in learning and memory. To investigate the potential impact of PGBs on cognition, we performed conditioned fear memory testing on strains displaying varying degrees of PGB burden, and a phenome-wide association scan of ~12,000 traits. Importantly, we did not find any evidence suggesting a negative impact of PGB burden on cognitive capacity. Taken together, we have identified a major modifier locus controlling PGB burden in the hippocampus and shed light on the genetic architecture and clinical relevance of this strikingly heterogeneous hippocampal phenotype.
Collapse
Affiliation(s)
- A Gómez-Pascual
- Department of Information and Communications Engineering, University of Murcia, Murcia, Spain
| | - D M Glikman
- University of Vienna, Vienna, Austria
- Department of Neuronal Cell Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria
| | - H X Ng
- Department of Cognitive Science University of California, San Diego, USA
| | - J E Tomkins
- Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, UK
- Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815
| | - L Lu
- Department of Genetics, Genomics and Informatics, University of Tennessee Health Center, Memphis, TN, USA
| | - Y Xu
- Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
| | - D G Ashbrook
- Department of Genetics, Genomics and Informatics, University of Tennessee Health Center, Memphis, TN, USA
| | | | - G Kempermann
- German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany
| | - J Killmar
- Department of Genetics, Genomics and Informatics, University of Tennessee Health Center, Memphis, TN, USA
| | - K Mozhui
- Department of Genetics, Genomics and Informatics, University of Tennessee Health Center, Memphis, TN, USA
- Department of Preventive Medicine, College of Medicine, University of Tennessee Health Center, Memphis, TN, USA
| | - R Aebersold
- Department of Biology, Institute of Molecular Systems Biology, ETH Zurich. Zurich, Switzerland
| | - E G Williams
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belval, Luxembourg
| | - R W Williams
- Department of Genetics, Genomics and Informatics, University of Tennessee Health Center, Memphis, TN, USA
| | - R W Overall
- Humboldt University of Berlin, Berlin, Germany
| | - M Jucker
- Department of Cellular Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
| | - D E M de Bakker
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany
| |
Collapse
|
20
|
Wang Z, Katsaros D, Wang J, Biglio N, Hernandez BY, Fei P, Lu L, Risch H, Yu H. Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival. Sci Rep 2023; 13:18962. [PMID: 37923775 PMCID: PMC10624674 DOI: 10.1038/s41598-023-45932-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2022] [Accepted: 10/25/2023] [Indexed: 11/06/2023] Open
Abstract
Host immunity involves various immune cells working in concert to achieve balanced immune response. Host immunity interacts with tumorigenic process impacting disease outcome. Clusters of different immune cells may reveal unique host immunity in relation to breast cancer progression. CIBERSORT algorithm was used to estimate relative abundances of 22 immune cell types in 3 datasets, METABRIC, TCGA, and our study. The cell type data in METABRIC were analyzed for cluster using unsupervised hierarchical clustering (UHC). The UHC results were employed to train machine learning models. Kaplan-Meier and Cox regression survival analyses were performed to assess cell clusters in association with relapse-free and overall survival. Differentially expressed genes by clusters were interrogated with IPA for molecular signatures. UHC analysis identified two distinct immune cell clusters, clusters A (83.2%) and B (16.8%). Memory B cells, plasma cells, CD8 positive T cells, resting memory CD4 T cells, activated NK cells, monocytes, M1 macrophages, and resting mast cells were more abundant in clusters A than B, whereas regulatory T cells and M0 and M2 macrophages were more in clusters B than A. Patients in cluster A had favorable survival. Similar survival associations were also observed in other independent studies. IPA analysis showed that pathogen-induced cytokine storm signaling pathway, phagosome formation, and T cell receptor signaling were related to the cell type clusters. Our finding suggests that different immune cell clusters may indicate distinct immune responses to tumor growth, suggesting their potential for disease management.
Collapse
Affiliation(s)
- Zhanwei Wang
- Cancer Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA
| | - Dionyssios Katsaros
- Department of Surgical Sciences, Gynecology, AOU Città della Salute, University of Torino, Turin, Italy
| | - Junlong Wang
- Cancer Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA
- Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, USA
| | - Nicholetta Biglio
- Division of Obstetrics and Gynecology, Department of Surgical Sciences, University of Torino School of Medicine, Mauriziano Hospital, Turin, Italy
| | - Brenda Y Hernandez
- Cancer Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA
| | - Peiwen Fei
- Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA
| | - Harvey Risch
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA
| | - Herbert Yu
- Cancer Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI, 96813, USA.
| |
Collapse
|
21
|
Huang XF, He Q, Shi HH, Hu HP, Lu L, Huang RM, Zhang XY, Xu YQ. [Mediating effects of obesity and metabolic factors in hyperuricemia and prehypertension]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:1599-1603. [PMID: 37875447 DOI: 10.3760/cma.j.cn112338-20230314-00145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 10/26/2023]
Abstract
Objective: To assess the mediating effects of obesity and metabolic factors in the relationship between hyperuricemia (HUA) and prehypertension. Methods: A total of 9 399 individuals were selected using a multistage stratified whole-group random sampling method from 90 villages (neighborhood committees) in 30 towns (streets) of 5 districts (counties) in Fuzhou. A total of 4 754 study subjects were included. A linear regression model was used to analyze the association of HUA with obesity and metabolic factors. Single-factor and multi-factor logistic regression models were used to analyze the association of HUA, obesity, and metabolic factors with prehypertension. Mediating effects models were used to analyze the mediating effects of obesity and metabolic factors on the association between HUA and prehypertension. Results: After adjusting for confounders, the association between HUA and cholesterol, triglycerides, HDL-C, LDL-C, BMI, waist circumference, creatinine, and urea nitrogen were significantly correlated (P<0.001). HUA, waist circumference, BMI, and triglycerides were significantly associated with prehypertension (P<0.001). Waist circumference, BMI, and triglycerides mediated the relationship between HUA and prehypertension, with OR (95%CI) of 1.018 (1.007-1.027), 1.010 (1.002-1.018), and 1.010 (1.003-1.017) (P<0.001), with mediating proportions of 7.76%, 4.31%, and 4.31% respectively. No mediating effect of cholesterol, HDL-C, LDL-C, creatinine, and urea nitrogen was found on the relationship (P>0.05). Conclusions: Waist circumference, BMI, and triglycerides all had mediating effects in the association between HUA and prehypertension. For the general population, weight control, waist circumference, and a high-fat diet should be used to reduce the occurrence of prehypertension.
Collapse
Affiliation(s)
- X F Huang
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China School of Public Health, Fujian Medical University, Fuzhou 350004, China
| | - Q He
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China School of Public Health, Fujian Medical University, Fuzhou 350004, China
| | - H H Shi
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China School of Public Health, Fujian Medical University, Fuzhou 350004, China
| | - H P Hu
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China School of Public Health, Fujian Medical University, Fuzhou 350004, China
| | - L Lu
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China
| | - R M Huang
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China
| | - X Y Zhang
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China School of Public Health, Fujian Medical University, Fuzhou 350004, China
| | - Y Q Xu
- Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350004, China School of Public Health, Fujian Medical University, Fuzhou 350004, China
| |
Collapse
|
22
|
Zhang Y, Ye X, Ge J, Guo D, Zheng D, Yu H, Chen Y, Yao G, Lu Z, Yuille A, Lu L, Jin D, Yan S. Deep Learning-Based Multi-Modality Segmentation of Primary Gross Tumor Volume in CT and MRI for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2023; 117:e498. [PMID: 37785566 DOI: 10.1016/j.ijrobp.2023.06.1739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The delineation of primary gross tumor volume (GTV) of nasopharyngeal carcinoma (NPC) is an essential step for radiotherapy planning. In clinical practice, radiation oncologists manually delineate the GTV in planning CT with the help of diagnostic MRI. This is because NPC tumors are closely adjacent to many important anatomic structures, and CT and MRI provide complementary strength to accurately determine the tumor extension boundary. Manual delineation is time-consuming with the potential registration errors between MRI and CT decreasing the delineation accuracy. In this study, we propose a fully automated GTV segmentation method based on CT and MRI by first aligning MRI to CT, and then, segmenting the GTV using a multi-modality deep learning model. MATERIALS/METHODS We collected 104 nasopharyngeal carcinoma patients with both planning CT and diagnostic MRI scans (T1 & T2 phases). An experienced radiation oncologists manually delineated the GTV, which was further examined by another senior radiation oncologist. Then, a coarse to fine cross-modality registration from MRI to CT was conducted as follows: (1) A rigid transformation was performed on MRI to roughly align MRI to CT with similar anatomic position. (2) Then, the region of interest (RoI) on both CT and rigid-transformed MRI were cropped. (3) A leading cross-modality deformable registration algorithm, named DEEDS, was applied on the cropped MRI and CT RoIs to find an accurate local alignment. Next, using CT and registered MRI as the combined input, a multi-modality deep segmentation network based on nnUNet was trained to generate the GTV prediction. 20% patients were randomly selected as the unseen testing set to quantitatively evaluate the performance. RESULTS The quantitative NPC GTV segmentation performance is summarized in Table 1. The deep segmentation model using CT alone achieved reasonable high performance with 76.6% Dice score and 1.34mm average surface distance (ASD). When both CT and registered MRI were used, the segmentation model further improved the performance by 0.9% Dice score increase and 11% relative ASD error reduction, demonstrating the complementary strength of CT and MRI in determining NPC GTV. Notably, the achieved 77.5% Dice score and 1.19mm ASD by the multimodality model is among the top performing results reported in recent automatic NPC GTV segmentation using either CT or MRI modality. CONCLUSION We developed a fully automated multi-modal deep-learning model for NPC GTV segmentation. The developed model can segment the NPC GTV in high accuracy. With further optimization and validation, this automated model has potential to standardize the NPC GTV segmentation and significantly decrease the workload of radiation oncologists in clinical practice.
Collapse
Affiliation(s)
- Y Zhang
- Johns Hopkins University, Baltimore, MD
| | - X Ye
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - J Ge
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - D Guo
- Alibaba Group (US) Inc., New York, NY
| | - D Zheng
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - H Yu
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Y Chen
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - G Yao
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Z Lu
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - A Yuille
- Johns Hopkins University, Baltimore, MD
| | - L Lu
- Alibaba Group (US) Inc., New York, NY
| | - D Jin
- Alibaba Group (US) Inc., New York, NY
| | - S Yan
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| |
Collapse
|
23
|
Palhares DM, Dasgupta A, Saifuddin M, Ho L, Lu L, Prasla S, Pena MLA, Karam I, Soliman H, Szumacher E, Chow E, Chen H, Vesprini D, Sahgal A, Czarnota GJ. A Novel Strategy to Enhance Radiotherapy Efficacy: Results from the Prospective Phase I Clinical Trial of MR-Guided Focused Ultrasound-Stimulated Microbubbles (MRgFUS+MB) Treatment for Breast Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e197. [PMID: 37784840 DOI: 10.1016/j.ijrobp.2023.06.1068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Preclinical in vitro and in vivo studies have demonstrated that tumor cell death can be enhanced 10- to 40-fold when radiotherapy (RT) is combined with focused-ultrasound (FUS)-stimulated microbubbles (MB) treatment. MBs are gas microspheres used as intravascular contrast agents. The acoustic exposure of MBs within the target volume causes bubbles cavitation that induces perturbation of tumor vasculature. This activates apoptotic pathways responsible for the ablative effect of stereotactic body radiotherapy, which would otherwise require high-dose radiotherapy (>8-10 Gy/fraction) to be activated. Subsequent irradiation of an MB-sensitized tumor causes increased anoxic tumor killing, which occurs in addition to canonical RT-induced DNA damage. Given the compelling results of preclinical data, we conducted a phase I clinical trial of magnetic resonance (MR)-guided FUS-stimulated MBs (MRgFUS+MB) treatment for breast cancer patients (pts). We report the safety and efficacy results of this new radio enhancement treatment. MATERIALS/METHODS This is a single-center, single-arm, investigator-initiated phase 1 clinical trial (NCT04431674). We included pts with stage I-IV breast cancer with tumor in situ for whom breast or chest wall RT was deemed adequate by a multidisciplinary team. Pts were excluded if they had contraindications for contrast-enhanced MR or MB administration. Pts underwent 2-3 MRgFUS+MB treatments throughout the RT course. We used an MR-coupled FUS-device operating at 500 KHz and 540 kPa peak negative pressure to deliver the treatment. The FUS sonicated intravenously administrated MB within the MR-guided target volume. Pts were monitored for 30-min post-procedure and subsequently treated with RT. The primary outcome was acute toxicity per Common Terminology for Adverse Events V5.0. Secondary outcomes were radiological response at 3 months and local control (LC) at 1 year. Kaplan-Meier method was used to estimate local control. All pts signed a written consent form before study participation. RESULTS We enrolled 18 females with 20 primary breast cancer treated with MRgFUS+MB therapy. The median age was 60 years (range, 44-90). The molecular subtypes consisted of basal-like (n = 3/20), luminal (n = 11/20), and HER2-enriched (n = 6/20). The prescribed dose was 20 Gy/5 fractions (n = 8/20), 30-35 Gy/5 fractions (n = 7/20), 30-40 Gy/10 fractions (n = 3/20), and 66 Gy/33 fractions (n = 2/20). The median follow-up was 9 months (range, 0.3-29). All pts completed the planned MRgFUS+MB treatments. The only MRgFUS+MB treatment-related toxicity consisted of Grade 1 allergic reaction (mild cough) 30 minutes after the last MB injection. All worst acute toxicities were radiation dermatitis (Grade 3 = 2/20, Grade 2 = 2/20, Grade 1 = 14/20). At 3 months, 75% had partial (n = 6/20) or complete (n = 9/20) response, with a single progression. The LC rate at 1 year was 86%. CONCLUSION MRgFUS+MB was a safe and efficient treatment that provided durable responses.
Collapse
Affiliation(s)
- D M Palhares
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - A Dasgupta
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - M Saifuddin
- Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - L Ho
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - L Lu
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - S Prasla
- Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - M L A Pena
- Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - I Karam
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - H Soliman
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - E Szumacher
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - E Chow
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - H Chen
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - D Vesprini
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - A Sahgal
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| | - G J Czarnota
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
24
|
Wang Y, Zhu J, Guo D, Yan K, Lu L, Wang S, Jin D, Ye X, Wang Q. Deep Learning for Automatic Prediction of Lymph Node Station Metastasis in Esophageal Cancer Patients from Contrast-Enhanced CT. Int J Radiat Oncol Biol Phys 2023; 117:S55. [PMID: 37784523 DOI: 10.1016/j.ijrobp.2023.06.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The diagnosis of lymph node (LN) metastasis in computed tomography (CT) is an essential yet challenging task in esophageal cancer staging and treatment planning. Although criteria (e.g., RECIST, morphological/texture features) are proposed to predict LN metastasis, the diagnostic accuracy remains low with sensitivity <50% and specificity <75%, as reported in previous studies. Deep learning (DL) has the potential to address this issue by learning from large-scale labeled data. However, due to the practical surgery procedure in lymph node dissection, it is difficult to pair the metastasis of individual LN reported in the pathology report to the LN instance found in the CT image. Hence, in this study, we first use pathology reports to determine the LNS metastasis, then develop a multiple instance deep learning (MIDL) model to predict lymph node station (LNS) metastasis. MATERIALS/METHODS We collected 1200 esophageal cancer patients with preoperative contrast-enhanced CT before surgery. A recently developed automatic mediastinal LNS segmentation model was first applied to segment LNS of 1 to 8 based on the IASLC protocol. For each LNS, the local CT region of interest (ROI) was cropped to generate a station-wise CT patch, where the LNS was labeled as metastatic if at least one metastatic LN was indicated in the pathology report. Using the station-wise CT patch and LNS label, we train a 3D MIDL model, MobileNetV3, to predict LNS metastasis. To better provide the LN position priors in MIDL, LN instances (with a short axis >4mm) were also segmented using an automatic LN detection algorithm and were added to the MIDL model as an auxiliary input. Five-fold cross-validation was conducted to evaluate the MIDL performance. RESULTS The MIDL model's performance is summarized in Table 1. The MIDL model incorporating an additional LN instance mask demonstrated a superior overall AUC of 0.7539, surpassing the model without the LN mask input by 2.93%. The specificity was evaluated at a threshold resulting in a recall of 0.7, and the best model outperformed the CT input model in terms of specificity by 2.11%. This highlights the value of including the LN position prior to the MIDL model. Notably, when a threshold was set to result in a specificity of 75%, the best MIDL model demonstrated a significantly higher recall compared to the previously reported clinical diagnostic recall (39.7% vs. 63.21%). CONCLUSION We developed a MIDL classification model to predict LNS metastasis using CT scans of 1200 patients. Our findings suggest that the MIDL model can substantially improve LNS metastasis prediction and has the potential to play an essential role in cancer staging, treatment planning, and prognostic analysis.
Collapse
Affiliation(s)
- Y Wang
- Alibaba Group (US) Inc., New York, NY
| | - J Zhu
- Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, China
| | - D Guo
- Alibaba Group (US) Inc., New York, NY
| | - K Yan
- Alibaba DAMO Academy, Beijing, China
| | - L Lu
- Alibaba Group (US) Inc., New York, NY
| | - S Wang
- School of Mechanical, Electrical and Information Engineering, Shandong University, Weihai, China
| | - D Jin
- Alibaba Group (US) Inc., New York, NY
| | - X Ye
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Q Wang
- Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, China
| |
Collapse
|
25
|
Wang P, Ge J, Zheng D, Zhu X, Liu J, Wu Y, Lu L, Yan S, Jin D, Ye X. Anatomy-Guided Deep Learning Model for Accurate and Robust Gross Tumor Volume Segmentation in Lung Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys 2023; 117:e71. [PMID: 37786077 DOI: 10.1016/j.ijrobp.2023.06.803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) In lung cancer radiation therapy, clinicians must outline the gross tumor volume (GTV) precisely on the planning computed tomography (pCT) for accurate radiation dose delivery. However, due to the limited contrast between tumor and normal tissues in lung parenchyma, accurate delineation of tumor boundaries is difficult leading to large inter-observer variation. In this study, we develop an anatomy-guided lung GTV deep segmentation model using a training cohort of multi-center datasets. The quantitative segmentation performance is evaluated on an independent dataset, where the inter-observer delineation variation is also assessed. MATERIALS/METHODS We collected and curated four publicly available lung datasets with GTV annotations (Lung-PET-CT-Dx, LIDC-IDRI, NSCLC-Radiogenomics and RIDER-CT) for deep learning model development. A total of 871 CT scans of patients, who were diagnosed with T1-T4 NSCLC, were available for training after data curation. The GTV annotations of primary tumor were examined and edited by two experienced radiation oncologists following the RTOG 1106 protocol. An anatomy-guided deep learning model was proposed, which consisted two deep networks. The first deep network used CT scan as input and segmented 4 anatomic organs (airway, heart, pulmonary artery and pulmonary vein), while the second deep network took both CT scan and these pre-segmented 4 organs as input and segmented the lung GTV. With the help of anatomic priors from 4 pre-segmented organs, the second deep network could more easily locate the GTV. We used nnUNet as the deep segmentation network. For evaluation, we used NSCLC-Radiomics as the testing dataset, which contains 20 CT scans each annotated by 5 radiation oncologists. The auto-segmented GTV were compared against each of the manual GTV reference. Inter-observer variation was also assessed using the 5 manual GTV references. RESULTS The proposed anatomic-guided lung GTV segmentation model achieved a mean Dice score of 82.4% and 95% Hausdorff distance (HD95) of 6.9mm when averaged cross 20 patients and 5 GTV references (Table 1), which outperformed the basic deep GTV segmentation model by markedly reducing 19.4% HD95 error. The performance of proposed model was also comparable to the inter-observer variation (Dice score: 82.4% vs. 81.9%, HD95 6.9 vs. 6.4mm), indicating that our model had similar reproducibility as human observers. CONCLUSION We developed and tested an anatomy-guided deep learning model for segmenting GTV in NSCLC patients. The model achieves high quantitative segmentation performance, which is comparable to the human observer variation. It can be potentially used in radiotherapy practice to improve GTV delineation consistency and reduce workloads of radiation oncologists.
Collapse
Affiliation(s)
- P Wang
- Alibaba DAMO Academy, Hangzhou, Zhejiang, China
| | - J Ge
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - D Zheng
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - X Zhu
- The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China
| | - J Liu
- The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China
| | - Y Wu
- The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China
| | - L Lu
- Alibaba Group (US) Inc., New York, NY
| | - S Yan
- Department of Radiation Oncology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
| | - D Jin
- Alibaba Group (US) Inc., New York, NY
| | - X Ye
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| |
Collapse
|
26
|
Han R, Ling C, Wang Y, Lu L. Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition. Cancer Cell Int 2023; 23:203. [PMID: 37716965 PMCID: PMC10504701 DOI: 10.1186/s12935-023-03051-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Accepted: 09/03/2023] [Indexed: 09/18/2023] Open
Abstract
Hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality but lacks effective treatments thus far. Although the emergence of immune checkpoint inhibitors in recent years has shed light on the treatment of HCC, a considerable number of patients are still unable to achieve durable and ideal clinical benefits. Therefore, refining the combination of immune checkpoint inhibitors (ICIs) to enhance the therapeutic effect has become a global research hotspot. Several histone deacetylase 2 inhibitors have shown advantages in ICIs in many solid cancers, except for HCC. Additionally, the latest evidence has shown that histone deacetylase 2 inhibition can regulate PD-L1 acetylation, thereby blocking the nuclear translocation of PD-L1 and consequently enhancing the efficacy of PD-1/PD-L1 inhibitors and improving anti-cancer immunity. Moreover, our team has recently discovered a novel HDAC2 inhibitor (HDAC2i), valetric acid (VA), that possesses great potential in HCC treatment as a monotherapy. Thus, a new combination strategy, combining HDAC2 inhibitors with ICIs, has emerged with significant development value. This perspective aims to ignite enthusiasm for exploring the application of ideal HDAC2 inhibitors with solid anti-tumor efficacy in combination with immunotherapy for HCC.
Collapse
Affiliation(s)
- Rui Han
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, P. R. China.
- Department of Chinese Medicine, Naval Medical University, Shanghai, 200433, P. R. China.
- Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, P. R. China.
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA.
- School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA.
- Yale Cancer Center, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA.
| | - Changquan Ling
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, P. R. China
- Department of Chinese Medicine, Naval Medical University, Shanghai, 200433, P. R. China
| | - Yuqian Wang
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, P. R. China
- Department of Chinese Medicine, Naval Medical University, Shanghai, 200433, P. R. China
| | - Lingeng Lu
- School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA
- Yale Cancer Center, Yale University, 60 College Street, New Haven, CT, 06520-8034, USA
| |
Collapse
|
27
|
Wang Y, Lu L, Ling C, Zhang P, Han R. Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors. Nutrients 2023; 15:3984. [PMID: 37764768 PMCID: PMC10537481 DOI: 10.3390/nu15183984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 09/09/2023] [Accepted: 09/12/2023] [Indexed: 09/29/2023] Open
Abstract
Breast cancer (BC) is a lethal malignancy with high morbidity and mortality but lacks effective treatments thus far. Despite the introduction of immune checkpoint inhibitors (ICIs) (including PD-1/PD-L1 inhibitors), durable and optimal clinical benefits still remain elusive for a considerable number of BC patients. To break through such a dilemma, novel ICI-based combination therapy has been explored for enhancing the therapeutic effect. Recent evidence has just pointed out that the HDAC2 inhibitor (HDAC2i), which has been proven to exhibit an anti-cancer effect, can act as a sensitizer for ICIs therapy. Simultaneously, dietary intervention, as a crucial supportive therapy, has been reported to provide ingredients containing HDAC2 inhibitory activity. Thus, the novel integration of dietary intervention with ICIs therapy may offer promising possibilities for improving treatment outcomes. In this study, we first conducted the differential expression and prognostic analyses of HDAC2 and BC patients using the GENT2 and Kaplan-Meier plotter platform. Then, we summarized the potential diet candidates for such an integrated therapeutic strategy. This article not only provides a whole new therapeutic strategy for an HDAC2i-containing diet combined with PD-1/PD-L1 inhibitors for BC treatment, but also aims to ignite enthusiasm for exploring this field.
Collapse
Affiliation(s)
- Yuqian Wang
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
- Department of Chinese Medicine, Naval Medical University, Shanghai 200433, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT 06520, USA
- School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT 06520, USA
- Yale Cancer Center, Yale University, 60 College Street, New Haven, CT 06520, USA
| | - Changquan Ling
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
- Department of Chinese Medicine, Naval Medical University, Shanghai 200433, China
| | - Ping Zhang
- Center for Integrative Conservation, Yunnan Key Laboratory for the Conservation of Tropical Rainforests and Asian Elephants, Xishuangbanna Tropical Botanical Garden, Xishuangbanna 666303, China
| | - Rui Han
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
- Department of Chinese Medicine, Naval Medical University, Shanghai 200433, China
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, 60 College Street, New Haven, CT 06520, USA
- School of Medicine, Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT 06520, USA
- Yale Cancer Center, Yale University, 60 College Street, New Haven, CT 06520, USA
- Department of Oncology, The First Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangzhou 510405, China
| |
Collapse
|
28
|
Zeng H, Xu M, Xie Y, Nawrocki S, Morze J, Ran X, Shan T, Xia C, Wang Y, Lu L, Yu XQ, Azeredo CM, Ji JS, Yuan X, Curi-Quinto K, Liu Y, Liu B, Wang T, Ping H, Giovannucci EL. Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study. EClinicalMedicine 2023; 62:102138. [PMID: 37593228 PMCID: PMC10430154 DOI: 10.1016/j.eclinm.2023.102138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 07/18/2023] [Accepted: 07/19/2023] [Indexed: 08/19/2023] Open
Abstract
Background Racial/ethnic disparities in prostate cancer are reported in the United States (US). However, long-term trends and contributors of racial/ethnic disparities in all-cause and cause-specific death among patients with prostate cancer remain unclear. We analysed the trends and contributors of racial/ethnic disparities in prostate cancer survivors according to the cause of death in the US over 25 years. Methods In this retrospective, population-based longitudinal cohort study, we identified patients diagnosed with first primary prostate cancer between 1995 and 2019, with follow-up until Dec 31, 2019, using population-based cancer registries' data from the Surveillance, Epidemiology, and End Results (SEER) Program. We calculated the cumulative incidence of death for each racial/ethnic group (Black, white, Hispanic, Asian or Pacific Islander [API], and American Indian or Alaska Native [AI/AN] people), by diagnostic period and cause of death. We quantified absolute disparities using rate changes for the 5-year cumulative incidence of death between racial/ethnic groups and diagnostic periods. We estimated relative (Hazard ratios [HR]) racial/ethnic disparities and the percentage of potential factors contributed to racial/ethnic disparities using Cox regression models. Findings Despite a decreasing trend in the cumulative risk of death across five racial/ethnic groups, AI/AN and Black patients consistently had the highest rate of death between 1995 and 2019 with an adjusted HR of 1.48 (1.40-1.58) and 1.40 (1.38-1.42) respectively. The disparities in all-cause mortality between AI/AN and white patients increased over time, with adjusted HR 1.32 (1.17-1.49) in 1995-1999 and 1.95 (1.53-2.49) in 2015-2019. Adjustment of stage at diagnosis, initial treatment, tumor grade, and household income explained 33% and 24% of the AI/AN-white and Black-white disparities in all-cause death among patients with prostate cancer. Interpretation The enduring racial/ethnic disparities in patients with prostate cancer, call for new interventions to eliminate health disparities. Our study provides important evidence and ways to address racial/ethnic inequality. Funding National Key R&D Program of China, National Natural Science Foundation of China, Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, the Open Research Fund from Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Key Projects of Philosophy and Social Sciences Research, Ministry of Education of China.
Collapse
Affiliation(s)
- Hongmei Zeng
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Mengyuan Xu
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Yingwei Xie
- Department of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
| | - Sergiusz Nawrocki
- Department of Oncology, Collegium Medicum University of Warmia and Mazury in Olsztyn, Wojska Polskiego 37, 10-228 Olsztyn, Poland
- Department of Radiotherapy, Hospital of the Ministry of Internal Affairs with Warmia and Mazury Oncology Center in Olsztyn, Wojska Polskiego 37, 10-228 Olsztyn, Poland
| | - Jakub Morze
- College of Medical Sciences, SGMK University, Olsztyn, Poland
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Xianhui Ran
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Tianhao Shan
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Changfa Xia
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Yixin Wang
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale Cancer Center, Yale University, New Haven, CT 06510, USA
| | - Xue Qin Yu
- The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council New South Wales, Sydney, NSW, Australia
| | | | - John S. Ji
- Vanke School of Public Health, Tsinghua University, Beijing, China
| | - Xiaomei Yuan
- Department of Outpatient, NO.20 Retired Cadre Sanatorium, Haidian District, Beijing
| | - Katherine Curi-Quinto
- Universidad San Ignacio de Loyola, Facultad de Ciencias de la Salud, Lima 15024, Peru
- Instituto de Investigación Nutricional (IIN), Lima 15024, Peru
| | - Yuexin Liu
- Department of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
| | - Bingsheng Liu
- School of Public Policy and Administration, Chongqing University, No.174 Shazhengjie, Shapingba District, Chongqing, China
| | - Tao Wang
- School of Public Policy and Administration, Chongqing University, No.174 Shazhengjie, Shapingba District, Chongqing, China
| | - Hao Ping
- Department of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
- Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University and Capital Medical University, Beijing Tongren Hospital, Beijing, China
| | - Edward L. Giovannucci
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| |
Collapse
|
29
|
Fu R, Sun K, Wang X, Liu B, Wang T, Morze J, Nawrocki S, An L, Zhang S, Li L, Wang S, Chen R, Sun K, Han B, Lin H, Wang H, Liu D, Wang Y, Li Y, Zhang Q, Mu H, Geng Q, Sun F, Zhao H, Zhang X, Lu L, Mei D, Zeng H, Wei W. Survival differences between the USA and an urban population from China for all cancer types and 20 individual cancers: a population-based study. Lancet Reg Health West Pac 2023; 37:100799. [PMID: 37693879 PMCID: PMC10485681 DOI: 10.1016/j.lanwpc.2023.100799] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2023] [Revised: 04/13/2023] [Accepted: 05/07/2023] [Indexed: 09/12/2023]
Abstract
Background The systematic comparison of cancer survival between China and the USA is rare. Here we aimed to assess the magnitude of survival disparities and disentangle the impact of the stage at diagnosis between a Chinese metropolitan city and the USA on cancer survival. Methods We included 11,046 newly diagnosed cancer patients in Dalian Cancer Registry, China, 2015, with the follow-up data for vital status until December 2020. We estimated age-standardised 5-year relative survival and quantified the excess hazard ratio (EHR) of death using generalised linear models for all cancers and 20 individual cancers. We compared these estimates with 17 cancer registries' data from the USA, using the Surveillance, Epidemiology, and End Results database. We further estimated the stage-specific survival for five major cancers by region. Findings Age-standardised 5-year relative survival for all patients in Dalian was lower than that in the USA (49.9% vs 67.9%). By cancer types, twelve cancers with poorer prognosis were observed in Dalian compared to the USA, with the largest gap seen in prostate cancer (Dalian: 55.8% vs USA: 96.0%). However, Dalian had a better survival for lung cancer, cervical cancer, and bladder cancer. Dalian patients had a lower percentage of stage Ⅰ colorectal cancer (Dalian: 17.9% vs USA: 24.2%) and female breast cancer (Dalian: 40.9% vs USA: 48.9%). However, we observed better stage-specific survival among stage Ⅰ-Ⅱ lung cancer patients in Dalian than in the USA. Interpretation This study suggests that although the overall prognosis for patients was better in the USA than in Dalian, China, survival deficits existed in both countries. Improvement in cancer early detection and cancer care are needed in both countries. Funding National Key R&D Program (2021YFC2501900, 2022YFC3600805), Major State Basic Innovation Program of the Chinese Academy of Medical Sciences (2021-I2M-1-010, 2021-I2M-1-046), and Talent Incentive Program of Cancer Hospital of Chinese Academy of Medical Sciences.
Collapse
Affiliation(s)
- Ruiying Fu
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Ke Sun
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Xiaofeng Wang
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Bingsheng Liu
- School of Public Policy and Administration, Chongqing University, No.174 Shazhengjie, Shapingba District, Chongqing, 400044, China
| | - Tao Wang
- School of Public Policy and Administration, Chongqing University, No.174 Shazhengjie, Shapingba District, Chongqing, 400044, China
| | - Jakub Morze
- College of Medical Sciences, SGMK University, Olsztyn, Poland
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA
| | - Sergiusz Nawrocki
- Department of Oncology, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-228, Olsztyn, Poland
| | - Lan An
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Siwei Zhang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Li Li
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Shaoming Wang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Ru Chen
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Kexin Sun
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Bingfeng Han
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Hong Lin
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Huinan Wang
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Dan Liu
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Yang Wang
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Youwei Li
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Qian Zhang
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Huijuan Mu
- Liaoning Provincial Center for Disease Control and Prevention, Shenyang, 110005, China
| | - Qiushuo Geng
- School of Medical Device, Shenyang Pharmaceutical University, Benxi, 117004, China
| | - Feng Sun
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China
| | - Haitao Zhao
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100021, China
| | - Xuehong Zhang
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale Cancer Center, Yale University, New Haven, CT, 06520, USA
- Yale Cancer Center and Center for Biomedical Data Science, Yale University, 60 College Street, New Haven, CT, 06520, USA
| | - Dan Mei
- Dalian Center for Disease Control and Prevention, Liaoning, 116035, China
| | - Hongmei Zeng
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Wenqiang Wei
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| |
Collapse
|
30
|
Yao Y, Yao J, Chen S, Zhang X, Meng H, Li Y, Lu L. Psychological Capital and Self-Acceptance Modified the Association of Depressive Tendency with Self-Rated Health of College Students in China during the COVID-19 Pandemic. Behav Sci (Basel) 2023; 13:552. [PMID: 37503999 PMCID: PMC10376835 DOI: 10.3390/bs13070552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Revised: 06/20/2023] [Accepted: 06/29/2023] [Indexed: 07/29/2023] Open
Abstract
BACKGROUND To explore the association between the self-reported health status, depressive tendency, psychological capital, and self-acceptance of college students in China during the COVID-19 pandemic. METHODS Using the online survey platform "questionnaire star", a two-phase cross-sectional study was conducted on a total number of 1438 undergraduates with informed consents. The questionnaires of Self-Rated Health Measurement Scale (SRHMS), the Center for Epidemiological Studies-Depression Scale (CES-D), Psychological Capital Questionnaire (PCQ-24), and self-acceptance questionnaire were administered to each participant. RESULTS Male college students had significantly higher depressive tendency scores than female (17.59 vs. 15.82) (p < 0.01). College students having no siblings had significantly higher psychological capital scores than those having siblings (108.63 vs. 105.60) (p < 0.05). Exercise had significantly positive associations with self-rated health, psychological capital, and self-acceptance scores, while online time per day had significantly negative associations. Multivariate analysis showed that the interaction between depressive tendency, psychological capital, and self-acceptance was statistically significant (β = 0.004, p = 0.013 for phase 1 and β = 0.002, p = 0.025 for phase 2) in health status with depressive tendency ranking the top (β = -0.54 for phase 1 and -0.41 for phase 2, p < 0.001). Mediation analysis showed that psychological capital and self-acceptance modified the association of depressive tendency with health status. CONCLUSION Physical exercise is beneficial to both physical and psychological health. Depressive tendency is the main risk factor that associates with self-rated health. Regardless of depressive tendency level, high psychological capital and self-acceptance could improve college students' health.
Collapse
Affiliation(s)
- Yongcheng Yao
- School of Mathematics and Statistics, Zhengzhou Normal University, Zhengzhou 450044, China
| | - Junyan Yao
- College of Elementary Education, Capital Normal University, Beijing 100048, China
| | - Shuyan Chen
- School of Mathematics and Statistics, Zhengzhou Normal University, Zhengzhou 450044, China
| | - Xiaohui Zhang
- School of Mathematics and Statistics, Zhengzhou Normal University, Zhengzhou 450044, China
| | - Hongling Meng
- School of Mathematics and Statistics, Zhengzhou Normal University, Zhengzhou 450044, China
| | - Yuping Li
- School of Mathematics and Statistics, Zhengzhou Normal University, Zhengzhou 450044, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
- School of Medicine, Yale University, New Haven, CT 06520-8034, USA
| |
Collapse
|
31
|
Cartmel B, Li F, Zhou Y, Gottlieb L, Lu L, Mszar R, Harrigan M, Ligibel JA, Gogoi R, Schwartz PE, Risch HA, Irwin ML. Randomized trial of exercise on cancer-related blood biomarkers and survival in women with ovarian cancer. Cancer Med 2023; 12:15492-15503. [PMID: 37269192 PMCID: PMC10417064 DOI: 10.1002/cam4.6187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 04/13/2023] [Accepted: 05/21/2023] [Indexed: 06/04/2023] Open
Abstract
BACKGROUND In randomized trials in women with breast cancer, exercise has been shown to have beneficial effects on cancer-related circulating biomarkers that may impact survival. Such studies are lacking for ovarian cancer. METHODS This secondary analysis of a published randomized controlled trial examined the impact of a 6-month exercise intervention versus attention-control on change in prespecified circulating biomarkers (cancer antigen 125 (CA-125), C-reactive protein (CRP), insulin-like growth factor-1(IGF-1), insulin and leptin) in a subset of participants who provided a fasting blood draw (N = 104/144) at enrollment and at 6 months. Change in biomarkers between study arms was compared using a linear mixed effects model analysis. An exploratory analysis of the exercise intervention versus attention-control on all-cause mortality included all (N = 144) participants. All statistical tests were two-sided. RESULTS Participants included in the biomarker analysis were 57.0 ± 8.8 (mean ± SD) years old and 1.6 ± 0.9 years post-diagnosis. Adherence to the exercise intervention was 176.4 ± 63.5 min/week. Post intervention IGF-1 (group difference in change: -14.2 (-26.1 to -2.3) ng/mL (least squared means (95% CI))) and leptin (-8.9 (-16.5 to -1.4) ng/mL) were significantly reduced in the exercise group (N = 53) compared to those in attention-control (N = 51). No group difference in change was seen for CA-125 (p = 0.54), CRP (p = 0.95), or insulin (p = 0.37). With median follow-up of 70 months [range 6.6-105.4 months], 50/144 (34.7%) (exercise group; 24/74 (32.4%) versus attention-control group; 26/70 (37.1%)) participants died with no between group difference in overall survival (p = 0.99). CONCLUSIONS Further studies are needed to determine the clinical significance of exercise-induced changes in cancer-related circulating biomarkers in women with ovarian cancer.
Collapse
Affiliation(s)
- Brenda Cartmel
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
- Yale Cancer CenterNew HavenConnecticutUSA
| | - Fang‐yong Li
- Department of BiostatisticsYale School of Public HealthNew HavenConnecticutUSA
| | - Yang Zhou
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
- Yale Cancer CenterNew HavenConnecticutUSA
| | - Linda Gottlieb
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
| | - Lingeng Lu
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
- Yale Cancer CenterNew HavenConnecticutUSA
| | - Reed Mszar
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
| | - Maura Harrigan
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
| | - Jennifer A. Ligibel
- Department of Medical OncologyDana‐Farber Cancer InstituteBostonMassachusettsUSA
| | - Radhika Gogoi
- Gynecologic Oncology, Women and Children's InstituteGeisinger Health SystemDanvillePennsylvaniaUSA
- Present address:
Department of Obstetrics & GynecologyWayne State UniversityDetroitMichiganUSA
| | - Peter E. Schwartz
- Yale Cancer CenterNew HavenConnecticutUSA
- Section of Medical Oncology, Department of Internal MedicineYale School of MedicineNew HavenConnecticutUSA
| | - Harvey A. Risch
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
- Yale Cancer CenterNew HavenConnecticutUSA
| | - Melinda L. Irwin
- Department of Chronic Disease EpidemiologyYale School of Public HealthNew HavenConnecticutUSA
- Yale Cancer CenterNew HavenConnecticutUSA
| |
Collapse
|
32
|
Abbasi R, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Alameddine JM, Alves AA, Amin NM, Andeen K, Anderson T, Anton G, Argüelles C, Ashida Y, Athanasiadou S, Axani S, Bai X, Balagopal V A, Barwick SW, Basu V, Baur S, Bay R, Beatty JJ, Becker KH, Tjus JB, Beise J, Bellenghi C, Benda S, BenZvi S, Berley D, Bernardini E, Besson DZ, Binder G, Bindig D, Blaufuss E, Blot S, Boddenberg M, Bontempo F, Book JY, Borowka J, Böser S, Botner O, Böttcher J, Bourbeau E, Bradascio F, Braun J, Brinson B, Bron S, Brostean-Kaiser J, Burley RT, Busse RS, Campana MA, Carnie-Bronca EG, Chen C, Chen Z, Chirkin D, Choi K, Clark BA, Clark K, Classen L, Coleman A, Collin GH, Connolly A, Conrad JM, Coppin P, Correa P, Cowen DF, Cross R, Dappen C, Dave P, De Clercq C, DeLaunay JJ, López DD, Dembinski H, Deoskar K, Desai A, Desiati P, de Vries KD, de Wasseige G, DeYoung T, Diaz A, Díaz-Vélez JC, Dittmer M, Dujmovic H, Dunkman M, DuVernois MA, Ehrhardt T, Eller P, Engel R, Erpenbeck H, Evans J, Evenson PA, Fan KL, Fazely AR, Fedynitch A, Feigl N, Fiedlschuster S, Fienberg AT, Finley C, Fischer L, Fox D, Franckowiak A, Friedman E, Fritz A, Fürst P, Gaisser TK, Gallagher J, Ganster E, Garcia A, Garrappa S, Gerhardt L, Ghadimi A, Glaser C, Glauch T, Glüsenkamp T, Goehlke N, Goldschmidt A, Gonzalez JG, Goswami S, Grant D, Grégoire T, Griswold S, Günther C, Gutjahr P, Haack C, Hallgren A, Halliday R, Halve L, Halzen F, Minh MH, Hanson K, Hardin J, Harnisch AA, Haungs A, Helbing K, Henningsen F, Hettinger EC, Hickford S, Hignight J, Hill C, Hill GC, Hoffman KD, Hoshina K, Hou W, Huang F, Huber M, Huber T, Hultqvist K, Hünnefeld M, Hussain R, Hymon K, In S, Iovine N, Ishihara A, Jansson M, Japaridze GS, Jeong M, Jin M, Jones BJP, Kang D, Kang W, Kang X, Kappes A, Kappesser D, Kardum L, Karg T, Karl M, Karle A, Katz U, Kauer M, Kellermann M, Kelley JL, Kheirandish A, Kin K, Kiryluk J, Klein SR, Kochocki A, Koirala R, Kolanoski H, Kontrimas T, Köpke L, Kopper C, Kopper S, Koskinen DJ, Koundal P, Kovacevich M, Kowalski M, Kozynets T, Krupczak E, Kun E, Kurahashi N, Lad N, Gualda CL, Lanfranchi JL, Larson MJ, Lauber F, Lazar JP, Lee JW, Leonard K, Leszczyńska A, Li Y, Lincetto M, Liu QR, Liubarska M, Lohfink E, Mariscal CJL, Lu L, Lucarelli F, Ludwig A, Luszczak W, Lyu Y, Ma WY, Madsen J, Mahn KBM, Makino Y, Mancina S, Mariş IC, Martinez-Soler I, Maruyama R, McHale S, McElroy T, McNally F, Mead JV, Meagher K, Mechbal S, Medina A, Meier M, Meighen-Berger S, Merckx Y, Micallef J, Mockler D, Montaruli T, Moore RW, Morik K, Morse R, Moulai M, Mukherjee T, Naab R, Nagai R, Nahnhauer R, Naumann U, Necker J, Nguyen LV, Niederhausen H, Nisa MU, Nowicki SC, Nygren D, Pollmann AO, Oehler M, Oeyen B, Olivas A, O'Sullivan E, Pandya H, Pankova DV, Park N, Parker GK, Paudel EN, Paul L, de Los Heros CP, Peters L, Peterson J, Philippen S, Pieper S, Pizzuto A, Plum M, Popovych Y, Porcelli A, Rodriguez MP, Pries B, Przybylski GT, Raab C, Rack-Helleis J, Raissi A, Rameez M, Rawlins K, Rea IC, Rechav Z, Rehman A, Reichherzer P, Reimann R, Renzi G, Resconi E, Reusch S, Rhode W, Richman M, Riedel B, Roberts EJ, Robertson S, Roellinghoff G, Rongen M, Rott C, Ruhe T, Ryckbosch D, Cantu DR, Safa I, Saffer J, Salazar-Gallegos D, Sampathkumar P, Herrera SES, Sandrock A, Santander M, Sarkar S, Sarkar S, Satalecka K, Schaufel M, Schieler H, Schindler S, Schmidt T, Schneider A, Schneider J, Schröder FG, Schumacher L, Schwefer G, Sclafani S, Seckel D, Seunarine S, Sharma A, Shefali S, Shimizu N, Silva M, Skrzypek B, Smithers B, Snihur R, Soedingrekso J, Sogaard A, Soldin D, Spannfellner C, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stein R, Stettner J, Stezelberger T, Stokstad B, Stürwald T, Stuttard T, Sullivan GW, Taboada I, Ter-Antonyan S, Thwaites J, Tilav S, Tischbein F, Tollefson K, Tönnis C, Toscano S, Tosi D, Trettin A, Tselengidou M, Tung CF, Turcati A, Turcotte R, Turley CF, Twagirayezu JP, Ty B, Elorrieta MAU, Valtonen-Mattila N, Vandenbroucke J, van Eijndhoven N, Vannerom D, van Santen J, Veitch-Michaelis J, Verpoest S, Walck C, Wang W, Watson TB, Weaver C, Weigel P, Weindl A, Weiss MJ, Weldert J, Wendt C, Werthebach J, Weyrauch M, Whitehorn N, Wiebusch CH, Willey N, Williams DR, Wolf M, Wrede G, Wulff J, Xu XW, Yanez JP, Yildizci E, Yoshida S, Yu S, Yuan T, Zhang Z, Zhelnin P. Observation of high-energy neutrinos from the Galactic plane. Science 2023; 380:1338-1343. [PMID: 37384687 DOI: 10.1126/science.adc9818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Accepted: 05/04/2023] [Indexed: 07/01/2023]
Abstract
The origin of high-energy cosmic rays, atomic nuclei that continuously impact Earth's atmosphere, is unknown. Because of deflection by interstellar magnetic fields, cosmic rays produced within the Milky Way arrive at Earth from random directions. However, cosmic rays interact with matter near their sources and during propagation, which produces high-energy neutrinos. We searched for neutrino emission using machine learning techniques applied to 10 years of data from the IceCube Neutrino Observatory. By comparing diffuse emission models to a background-only hypothesis, we identified neutrino emission from the Galactic plane at the 4.5σ level of significance. The signal is consistent with diffuse emission of neutrinos from the Milky Way but could also arise from a population of unresolved point sources.
Collapse
Affiliation(s)
- R Abbasi
- Department of Physics, Loyola University Chicago, Chicago, IL 60660, USA
| | - M Ackermann
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - J Adams
- Department of Physics and Astronomy, University of Canterbury, Private Bag 4800, Christchurch, New Zealand
| | - J A Aguilar
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - M Ahlers
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - M Ahrens
- Oskar Klein Centre and Department of Physics, Stockholm University, SE-10691 Stockholm, Sweden
| | - J M Alameddine
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - A A Alves
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - N M Amin
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - K Andeen
- Department of Physics, Marquette University, Milwaukee, WI, 53201, USA
| | - T Anderson
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - G Anton
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - C Argüelles
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| | - Y Ashida
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Athanasiadou
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - S Axani
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - X Bai
- Physics Department, South Dakota School of Mines and Technology, Rapid City, SD 57701, USA
| | - A Balagopal V
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S W Barwick
- Department of Physics and Astronomy, University of California, Irvine, CA 92697, USA
| | - V Basu
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Baur
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - R Bay
- Department of Physics, University of California, Berkeley, CA 94720, USA
| | - J J Beatty
- Department of Astronomy, Ohio State University, Columbus, OH 43210, USA
- Department of Physics and Center for Cosmology and Astro-Particle Physics, Ohio State University, Columbus, OH 43210, USA
| | - K-H Becker
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - J Becker Tjus
- Fakultät für Physik & Astronomie, Ruhr-Universität Bochum, D-44780 Bochum, Germany
| | - J Beise
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - C Bellenghi
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - S Benda
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S BenZvi
- Department of Physics and Astronomy, University of Rochester, Rochester, NY 14627, USA
| | - D Berley
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - E Bernardini
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
- Università di Padova, I-35131 Padova, Italy
| | - D Z Besson
- Department of Physics and Astronomy, University of Kansas, Lawrence, KS 66045, USA
| | - G Binder
- Department of Physics, University of California, Berkeley, CA 94720, USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - D Bindig
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - E Blaufuss
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - S Blot
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - M Boddenberg
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Bontempo
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - J Y Book
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| | - J Borowka
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - S Böser
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - O Botner
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - J Böttcher
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - E Bourbeau
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - F Bradascio
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - J Braun
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - B Brinson
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA 30332, USA
| | - S Bron
- Département de physique nucléaire et corpusculaire, Université de Genève, CH-1211 Genève, Switzerland
| | | | - R T Burley
- Department of Physics, University of Adelaide, Adelaide, 5005, Australia
| | - R S Busse
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany
| | - M A Campana
- Department of Physics, Drexel University, Philadelphia, PA 19104, USA
| | - E G Carnie-Bronca
- Department of Physics, University of Adelaide, Adelaide, 5005, Australia
| | - C Chen
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA 30332, USA
| | - Z Chen
- Department of Physics and Astronomy, Stony Brook University, Stony Brook, NY 11794-3800, USA
| | - D Chirkin
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - K Choi
- Department of Physics, Sungkyunkwan University, Suwon 16419, Korea
| | - B A Clark
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - K Clark
- Department of Physics, Engineering Physics, and Astronomy, Queen's University, Kingston, ON K7L 3N6, Canada
| | - L Classen
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany
| | - A Coleman
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - G H Collin
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - A Connolly
- Department of Astronomy, Ohio State University, Columbus, OH 43210, USA
- Department of Physics and Center for Cosmology and Astro-Particle Physics, Ohio State University, Columbus, OH 43210, USA
| | - J M Conrad
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - P Coppin
- Vrije Universiteit Brussel, Dienst Elementary Particles, B-1050 Brussels, Belgium
| | - P Correa
- Vrije Universiteit Brussel, Dienst Elementary Particles, B-1050 Brussels, Belgium
| | - D F Cowen
- Department of Astronomy and Astrophysics, Pennsylvania State University, University Park, PA 16802, USA
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - R Cross
- Department of Physics and Astronomy, University of Rochester, Rochester, NY 14627, USA
| | - C Dappen
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - P Dave
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA 30332, USA
| | - C De Clercq
- Vrije Universiteit Brussel, Dienst Elementary Particles, B-1050 Brussels, Belgium
| | - J J DeLaunay
- Department of Physics and Astronomy, University of Alabama, Tuscaloosa, AL 35487, USA
| | - D Delgado López
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| | - H Dembinski
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - K Deoskar
- Oskar Klein Centre and Department of Physics, Stockholm University, SE-10691 Stockholm, Sweden
| | - A Desai
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - P Desiati
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - K D de Vries
- Vrije Universiteit Brussel, Dienst Elementary Particles, B-1050 Brussels, Belgium
| | - G de Wasseige
- Centre for Cosmology, Particle Physics and Phenomenology, Université catholique de Louvain, Louvain-la-Neuve, Belgium
| | - T DeYoung
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - A Diaz
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - J C Díaz-Vélez
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - M Dittmer
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany
| | - H Dujmovic
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - M Dunkman
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - M A DuVernois
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - T Ehrhardt
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - P Eller
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - R Engel
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
- Karlsruhe Institute of Technology, Institute of Experimental Particle Physics, D-76021 Karlsruhe, Germany
| | - H Erpenbeck
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - J Evans
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - P A Evenson
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - K L Fan
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - A R Fazely
- Department of Physics, Southern University, Baton Rouge, LA 70813, USA
| | - A Fedynitch
- Institute of Physics, Academia Sinica, Taipei, 11529, Taiwan
| | - N Feigl
- Institut für Physik, Humboldt-Universität zu Berlin, D-12489 Berlin, Germany
| | - S Fiedlschuster
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - A T Fienberg
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - C Finley
- Oskar Klein Centre and Department of Physics, Stockholm University, SE-10691 Stockholm, Sweden
| | - L Fischer
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - D Fox
- Department of Astronomy and Astrophysics, Pennsylvania State University, University Park, PA 16802, USA
| | - A Franckowiak
- Fakultät für Physik & Astronomie, Ruhr-Universität Bochum, D-44780 Bochum, Germany
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - E Friedman
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - A Fritz
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - P Fürst
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - T K Gaisser
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - J Gallagher
- Department of Astronomy, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - E Ganster
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - A Garcia
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| | - S Garrappa
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - L Gerhardt
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - A Ghadimi
- Department of Physics and Astronomy, University of Alabama, Tuscaloosa, AL 35487, USA
| | - C Glaser
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - T Glauch
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - T Glüsenkamp
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - N Goehlke
- Karlsruhe Institute of Technology, Institute of Experimental Particle Physics, D-76021 Karlsruhe, Germany
| | - A Goldschmidt
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - J G Gonzalez
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - S Goswami
- Department of Physics and Astronomy, University of Alabama, Tuscaloosa, AL 35487, USA
| | - D Grant
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - T Grégoire
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - S Griswold
- Department of Physics and Astronomy, University of Rochester, Rochester, NY 14627, USA
| | - C Günther
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - P Gutjahr
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - C Haack
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - A Hallgren
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - R Halliday
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - L Halve
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Halzen
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - M Ha Minh
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - K Hanson
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - J Hardin
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - A A Harnisch
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - A Haungs
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - K Helbing
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - F Henningsen
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - E C Hettinger
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - S Hickford
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - J Hignight
- Department of Physics, University of Alberta, Edmonton, Alberta, T6G 2E1 Canada
| | - C Hill
- Department of Physics and The International Center for Hadron Astrophysics, Chiba University, Chiba 263-8522, Japan
| | - G C Hill
- Department of Physics, University of Adelaide, Adelaide, 5005, Australia
| | - K D Hoffman
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - K Hoshina
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
- Earthquake Research Institute, University of Tokyo, Bunkyo, Tokyo 113-0032, Japan
| | - W Hou
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - F Huang
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - M Huber
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - T Huber
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - K Hultqvist
- Oskar Klein Centre and Department of Physics, Stockholm University, SE-10691 Stockholm, Sweden
| | - M Hünnefeld
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - R Hussain
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - K Hymon
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - S In
- Department of Physics, Sungkyunkwan University, Suwon 16419, Korea
| | - N Iovine
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - A Ishihara
- Department of Physics and The International Center for Hadron Astrophysics, Chiba University, Chiba 263-8522, Japan
| | - M Jansson
- Oskar Klein Centre and Department of Physics, Stockholm University, SE-10691 Stockholm, Sweden
| | - G S Japaridze
- The Center for Theoretical Studies of Physical Systems, Clark-Atlanta University, Atlanta, GA 30314, USA
| | - M Jeong
- Department of Physics, Sungkyunkwan University, Suwon 16419, Korea
| | - M Jin
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| | - B J P Jones
- Department of Physics, University of Texas at Arlington, Arlington, TX 76019, USA
| | - D Kang
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - W Kang
- Department of Physics, Sungkyunkwan University, Suwon 16419, Korea
| | - X Kang
- Department of Physics, Drexel University, Philadelphia, PA 19104, USA
| | - A Kappes
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany
| | - D Kappesser
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - L Kardum
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - T Karg
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - M Karl
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - A Karle
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - U Katz
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - M Kauer
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - M Kellermann
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - J L Kelley
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - A Kheirandish
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - K Kin
- Department of Physics and The International Center for Hadron Astrophysics, Chiba University, Chiba 263-8522, Japan
| | - J Kiryluk
- Department of Physics and Astronomy, Stony Brook University, Stony Brook, NY 11794-3800, USA
| | - S R Klein
- Department of Physics, University of California, Berkeley, CA 94720, USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - A Kochocki
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - R Koirala
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - H Kolanoski
- Institut für Physik, Humboldt-Universität zu Berlin, D-12489 Berlin, Germany
| | - T Kontrimas
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - L Köpke
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - C Kopper
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - S Kopper
- Department of Physics and Astronomy, University of Alabama, Tuscaloosa, AL 35487, USA
| | - D J Koskinen
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - P Koundal
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - M Kovacevich
- Department of Physics, Drexel University, Philadelphia, PA 19104, USA
| | - M Kowalski
- Institut für Physik, Humboldt-Universität zu Berlin, D-12489 Berlin, Germany
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - T Kozynets
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - E Krupczak
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - E Kun
- Fakultät für Physik & Astronomie, Ruhr-Universität Bochum, D-44780 Bochum, Germany
| | - N Kurahashi
- Department of Physics, Drexel University, Philadelphia, PA 19104, USA
| | - N Lad
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | | | - J L Lanfranchi
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - M J Larson
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - F Lauber
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - J P Lazar
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - J W Lee
- Department of Physics, Sungkyunkwan University, Suwon 16419, Korea
| | - K Leonard
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - A Leszczyńska
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - Y Li
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - M Lincetto
- Fakultät für Physik & Astronomie, Ruhr-Universität Bochum, D-44780 Bochum, Germany
| | - Q R Liu
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - M Liubarska
- Department of Physics, University of Alberta, Edmonton, Alberta, T6G 2E1 Canada
| | - E Lohfink
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - C J Lozano Mariscal
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany
| | - L Lu
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - F Lucarelli
- Département de physique nucléaire et corpusculaire, Université de Genève, CH-1211 Genève, Switzerland
| | - A Ludwig
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
- Department of Physics and Astronomy, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - W Luszczak
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - Y Lyu
- Department of Physics, University of California, Berkeley, CA 94720, USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - W Y Ma
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - J Madsen
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - K B M Mahn
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - Y Makino
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Mancina
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - I C Mariş
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - I Martinez-Soler
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| | - R Maruyama
- Department of Physics, Yale University, New Haven, CT 06520, USA
| | - S McHale
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - T McElroy
- Department of Physics, University of Alberta, Edmonton, Alberta, T6G 2E1 Canada
| | - F McNally
- Department of Physics, Mercer University, Macon, GA 31207-0001, USA
| | - J V Mead
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - K Meagher
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Mechbal
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - A Medina
- Department of Physics and Center for Cosmology and Astro-Particle Physics, Ohio State University, Columbus, OH 43210, USA
| | - M Meier
- Department of Physics and The International Center for Hadron Astrophysics, Chiba University, Chiba 263-8522, Japan
| | - S Meighen-Berger
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - Y Merckx
- Vrije Universiteit Brussel, Dienst Elementary Particles, B-1050 Brussels, Belgium
| | - J Micallef
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - D Mockler
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - T Montaruli
- Département de physique nucléaire et corpusculaire, Université de Genève, CH-1211 Genève, Switzerland
| | - R W Moore
- Department of Physics, University of Alberta, Edmonton, Alberta, T6G 2E1 Canada
| | - K Morik
- Computer Science Faculty, TU Dortmund University, D-44221 Dortmund, Germany
| | - R Morse
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - M Moulai
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - T Mukherjee
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - R Naab
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - R Nagai
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - R Nahnhauer
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - U Naumann
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - J Necker
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - L V Nguyen
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - H Niederhausen
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - M U Nisa
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - S C Nowicki
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - D Nygren
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | | | - M Oehler
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - B Oeyen
- Department of Physics and Astronomy, University of Gent, B-9000 Gent, Belgium
| | - A Olivas
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - E O'Sullivan
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - H Pandya
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - D V Pankova
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - N Park
- Department of Physics, Engineering Physics, and Astronomy, Queen's University, Kingston, ON K7L 3N6, Canada
| | - G K Parker
- Department of Physics, University of Texas at Arlington, Arlington, TX 76019, USA
| | - E N Paudel
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - L Paul
- Department of Physics, Marquette University, Milwaukee, WI, 53201, USA
| | - C Pérez de Los Heros
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - L Peters
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - J Peterson
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Philippen
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - S Pieper
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - A Pizzuto
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - M Plum
- Physics Department, South Dakota School of Mines and Technology, Rapid City, SD 57701, USA
| | - Y Popovych
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - A Porcelli
- Department of Physics and Astronomy, University of Gent, B-9000 Gent, Belgium
| | - M Prado Rodriguez
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - B Pries
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - G T Przybylski
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - C Raab
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - J Rack-Helleis
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - A Raissi
- Department of Physics and Astronomy, University of Canterbury, Private Bag 4800, Christchurch, New Zealand
| | - M Rameez
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - K Rawlins
- Department of Physics and Astronomy, University of Alaska Anchorage, Anchorage, AK 99508, USA
| | - I C Rea
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - Z Rechav
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - A Rehman
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - P Reichherzer
- Fakultät für Physik & Astronomie, Ruhr-Universität Bochum, D-44780 Bochum, Germany
| | - R Reimann
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - G Renzi
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - E Resconi
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - S Reusch
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - W Rhode
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - M Richman
- Department of Physics, Drexel University, Philadelphia, PA 19104, USA
| | - B Riedel
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - E J Roberts
- Department of Physics, University of Adelaide, Adelaide, 5005, Australia
| | - S Robertson
- Department of Physics, University of California, Berkeley, CA 94720, USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - G Roellinghoff
- Department of Physics, Sungkyunkwan University, Suwon 16419, Korea
| | - M Rongen
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - C Rott
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT 84112, USA
- Department of Physics, Sungkyunkwan University, Suwon 16419, Korea
| | - T Ruhe
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - D Ryckbosch
- Department of Physics and Astronomy, University of Gent, B-9000 Gent, Belgium
| | - D Rysewyk Cantu
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - I Safa
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - J Saffer
- Karlsruhe Institute of Technology, Institute of Experimental Particle Physics, D-76021 Karlsruhe, Germany
| | - D Salazar-Gallegos
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - P Sampathkumar
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - S E Sanchez Herrera
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - A Sandrock
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - M Santander
- Department of Physics and Astronomy, University of Alabama, Tuscaloosa, AL 35487, USA
| | - S Sarkar
- Department of Physics, University of Alberta, Edmonton, Alberta, T6G 2E1 Canada
| | - S Sarkar
- Department of Physics, University of Oxford, Parks Road, Oxford OX1 3PU, UK
| | - K Satalecka
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - M Schaufel
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - H Schieler
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - S Schindler
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - T Schmidt
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - A Schneider
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - J Schneider
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - F G Schröder
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - L Schumacher
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - G Schwefer
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - S Sclafani
- Department of Physics, Drexel University, Philadelphia, PA 19104, USA
| | - D Seckel
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - S Seunarine
- Department of Physics, University of Wisconsin, River Falls, WI 54022, USA
| | - A Sharma
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - S Shefali
- Karlsruhe Institute of Technology, Institute of Experimental Particle Physics, D-76021 Karlsruhe, Germany
| | - N Shimizu
- Department of Physics and The International Center for Hadron Astrophysics, Chiba University, Chiba 263-8522, Japan
| | - M Silva
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - B Skrzypek
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| | - B Smithers
- Department of Physics, University of Texas at Arlington, Arlington, TX 76019, USA
| | - R Snihur
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - J Soedingrekso
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - A Sogaard
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - D Soldin
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - C Spannfellner
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - G M Spiczak
- Department of Physics, University of Wisconsin, River Falls, WI 54022, USA
| | - C Spiering
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - M Stamatikos
- Department of Physics and Center for Cosmology and Astro-Particle Physics, Ohio State University, Columbus, OH 43210, USA
| | - T Stanev
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - R Stein
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - J Stettner
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - T Stezelberger
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - B Stokstad
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
| | - T Stürwald
- Department of Physics, University of Wuppertal, D-42119 Wuppertal, Germany
| | - T Stuttard
- Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen, Denmark
| | - G W Sullivan
- Department of Physics, University of Maryland, College Park, MD 20742, USA
| | - I Taboada
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA 30332, USA
| | - S Ter-Antonyan
- Department of Physics, Southern University, Baton Rouge, LA 70813, USA
| | - J Thwaites
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Tilav
- Bartol Research Institute and Department of Physics and Astronomy, University of Delaware, Newark, DE 19716, USA
| | - F Tischbein
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - K Tollefson
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - C Tönnis
- Institute of Basic Science, Sungkyunkwan University, Suwon 16419, Korea
| | - S Toscano
- Université Libre de Bruxelles, Science Faculty CP230, B-1050 Brussels, Belgium
| | - D Tosi
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - A Trettin
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - M Tselengidou
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - C F Tung
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA 30332, USA
| | - A Turcati
- Physik-department, Technische Universität München, D-85748 Garching, Germany
| | - R Turcotte
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - C F Turley
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - J P Twagirayezu
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - B Ty
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - M A Unland Elorrieta
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany
| | - N Valtonen-Mattila
- Department of Physics and Astronomy, Uppsala University, Box 516, S-75120 Uppsala, Sweden
| | - J Vandenbroucke
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - N van Eijndhoven
- Vrije Universiteit Brussel, Dienst Elementary Particles, B-1050 Brussels, Belgium
| | - D Vannerom
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - J van Santen
- Deutsches Elektronen-Synchrotron, D-15738 Zeuthen, Germany
| | - J Veitch-Michaelis
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Verpoest
- Department of Physics and Astronomy, University of Gent, B-9000 Gent, Belgium
| | - C Walck
- Oskar Klein Centre and Department of Physics, Stockholm University, SE-10691 Stockholm, Sweden
| | - W Wang
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - T B Watson
- Department of Physics, University of Texas at Arlington, Arlington, TX 76019, USA
| | - C Weaver
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - P Weigel
- Department of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - A Weindl
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - M J Weiss
- Department of Physics, Pennsylvania State University, University Park, PA 16802, USA
| | - J Weldert
- Institute of Physics, University of Mainz, Staudinger Weg 7, D-55099 Mainz, Germany
| | - C Wendt
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - J Werthebach
- Department of Physics, TU Dortmund University, D-44221 Dortmund, Germany
| | - M Weyrauch
- Karlsruhe Institute of Technology, Institute for Astroparticle Physics, D-76021 Karlsruhe, Germany
| | - N Whitehorn
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
- Department of Physics and Astronomy, University of California, Los Angeles, Los Angeles, CA 90095, USA
| | - C H Wiebusch
- Physikalisches Institut, RWTH Aachen University, D-52056 Aachen, Germany
| | - N Willey
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - D R Williams
- Department of Physics and Astronomy, University of Alabama, Tuscaloosa, AL 35487, USA
| | - M Wolf
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - G Wrede
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91058 Erlangen, Germany
| | - J Wulff
- Fakultät für Physik & Astronomie, Ruhr-Universität Bochum, D-44780 Bochum, Germany
| | - X W Xu
- Department of Physics, Southern University, Baton Rouge, LA 70813, USA
| | - J P Yanez
- Department of Physics, University of Alberta, Edmonton, Alberta, T6G 2E1 Canada
| | - E Yildizci
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - S Yoshida
- Department of Physics and The International Center for Hadron Astrophysics, Chiba University, Chiba 263-8522, Japan
| | - S Yu
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA
| | - T Yuan
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI 53706, USA
| | - Z Zhang
- Department of Physics and Astronomy, Stony Brook University, Stony Brook, NY 11794-3800, USA
| | - P Zhelnin
- Department of Physics and Laboratory for Particle Physics and Cosmology, Harvard University, Cambridge, MA 02138, USA
| |
Collapse
|
33
|
Chen S, Qiang JQ, Li YX, Sun YX, Duan L, Lu L, Li Y, Dong YY, Xia WB. [Exploration of clinical pathway-oriented optimal management diagnosis and treatment model for rare diseases]. Zhonghua Yi Xue Za Zhi 2023; 103:1797-1801. [PMID: 37305941 DOI: 10.3760/cma.j.cn112137-20221123-02475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
This study takes Cushing's syndrome, a rare disease, as a model, and adopts the path of "Plan, Do, Check, Action" (PDCA) to explore new methods to optimize the clinical path, can improve the quality and efficiency of diagnosis and treatment of rare diseases. After sorting out the problems existing in the previous diagnosis and treatment mode, our team optimizes the path in various ways and establishes a standard operation procedure (SOP) for the new path. In the evaluation of the optimized mode, 55 patients with Cushing's syndrome were admitted to the Department of Endocrinology, Peking Union Medical College Hospital, including 19 males and 36 females, aged (41.8±14.4) years (6-68 years). The pathway group (28 cases) and the control group (27 cases) were divided according to whether they were included in the new path management at the time of admission, and the effect of path optimization was assessed in terms of time, efficacy, safety and cost. The results showed that compared with the control group, the pathway group had a shorter time of hospitalization in the Department of Endocrinology and critical tests, such as blood cortisol rhythm, low-dose dexamethasone inhibition test, and bilateral inferior petrosal sinus sampling (all P<0.05). There was no significant differences in the decrease of total cortisol after operation, the incidence of postoperative complications, and hospitalization expenses (all P>0.05). The optimized path improves the medical efficiency while ensuring medical quality, safety and no increase in cost. This study proposes PDCA path optimization for complex diseases and establishes SOP process, which provides experience in management optimization for the patient-centered and clinical path-oriented diagnosis and treatment mode of rare diseases.
Collapse
Affiliation(s)
- S Chen
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission, Beijing 100730, China
| | - J Q Qiang
- Eight-Year Program of Clinical Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Y X Li
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission, Beijing 100730, China
| | - Y X Sun
- Eight-Year Program of Clinical Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - L Duan
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission, Beijing 100730, China
| | - L Lu
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission, Beijing 100730, China
| | - Y Li
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission, Beijing 100730, China
| | - Y Y Dong
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission, Beijing 100730, China
| | - W B Xia
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission, Beijing 100730, China
| |
Collapse
|
34
|
Deng JH, Huang XL, Liu XX, Sun J, Lu L. [The past, present and future of sleep medicine in China]. Beijing Da Xue Xue Bao Yi Xue Ban 2023; 55:567. [PMID: 37386684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 07/01/2023]
Abstract
Sleep is a highly conserved phenomenon in endotherms, and has a universal physiological function across all species. In mammals, sleep can be divided into two stages: rapid eye movement (REM) sleep and non-REM (NREM) sleep, which alternate in a cyclic manner. Humans spend about one-third of their lives asleep. Sufficient sleep is necessary for humans to sustain everyday functioning. Sleep plays an important role in regulating energy metabolism, immune defense, endocrine function, and the consolidation of memory process. With the development of social economy and the change of life style, sleep duration of the residents has gradually decreased and the incidence of sleep disturbances has increased. Sleep disturbances can lead to severe mental disorders, such as depression, anxiety disorders, dementia, and other mental diseases, and may increase the risk of physical diseases, such as chronic inflammation, heart disease, diabetes, hypertension, atherosclerosis and others. Maintaining good sleep is of great significance for developing social productive forces, promoting sustainable development of economic society, and is a necessary condition for carrying out the "Healthy China Strategy". The sleep research in China started in 1950s. After decades of development, researchers have made great progress in the molecular mechanisms of sleep and wakefulness, the pathogenesis of sleep disorders and the development of new therapies. With the advancement of science and technology and the public's attention to sleep, the level of clinical diagnosis and therapy of sleep disorders in China is gradually brought in line with international standards. The publication of diagnosis and treatment guidelines in the field of sleep medicine will promote the standardization of the construction. In the future, it is still necessary to promote the development of sleep medicine in the following aspects: Strengthening the professional training and discipline construction, improving the cooperation of sleep research, promoting the intelligent diagnosis and treatment of sleep disorders, and developing the new intervention strategies. Therefore, this review will comprehensively summarize the origin, current situation, and future expectations of sleep medicine in China, including discipline construction of sleep medicine, the number of sleep project grants, research findings, the status and progress of diagnosis and treatment of sleep disorders, and the development direction of sleep medicine.
Collapse
Affiliation(s)
- J H Deng
- Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China
| | - X L Huang
- Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China
| | - X X Liu
- Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China
| | - J Sun
- Pain Medicine Center, Peking University Third Hospital, Beijing 100191, China
| | - L Lu
- Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China
- Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China
- National Institute on Drug Dependence, Peking University & Beijing Key Laboratory of Drug Dependence Research, Beijing 100191, China
| |
Collapse
|
35
|
Lin G, Zhang Z, Lu Y, Geng J, Zhou Z, Lu L, Cao L. [A region-level contrastive learning-based deep model for glomerular ultrastructure segmentation on electron microscope images]. Nan Fang Yi Ke Da Xue Xue Bao 2023; 43:815-824. [PMID: 37313824 DOI: 10.12122/j.issn.1673-4254.2023.05.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
OBJECTIVE We propose a novel region- level self-supervised contrastive learning method USRegCon (ultrastructural region contrast) based on the semantic similarity of ultrastructures to improve the performance of the model for glomerular ultrastructure segmentation on electron microscope images. METHODS USRegCon used a large amount of unlabeled data for pre- training of the model in 3 steps: (1) The model encoded and decoded the ultrastructural information in the image and adaptively divided the image into multiple regions based on the semantic similarity of the ultrastructures; (2) Based on the divided regions, the first-order grayscale region representations and deep semantic region representations of each region were extracted by region pooling operation; (3) For the first-order grayscale region representations, a grayscale loss function was proposed to minimize the grayscale difference within regions and maximize the difference between regions. For deep semantic region representations, a semantic loss function was introduced to maximize the similarity of positive region pairs and the difference of negative region pairs in the representation space. These two loss functions were jointly used for pre-training of the model. RESULTS In the segmentation task for 3 ultrastructures of the glomerular filtration barrier based on the private dataset GlomEM, USRegCon achieved promising segmentation results for basement membrane, endothelial cells, and podocytes, with Dice coefficients of (85.69 ± 0.13)%, (74.59 ± 0.13)%, and (78.57 ± 0.16)%, respectively, demonstrating a good performance of the model superior to many existing image-level, pixel-level, and region-level self-supervised contrastive learning methods and close to the fully- supervised pre-training method based on the large- scale labeled dataset ImageNet. CONCLUSION USRegCon facilitates the model to learn beneficial region representations from large amounts of unlabeled data to overcome the scarcity of labeled data and improves the deep model performance for glomerular ultrastructure recognition and boundary segmentation.
Collapse
Affiliation(s)
- G Lin
- School of Biomedical Engineering//Guangdong Provincial Key Laboratory of Medical Image Processing//Guangdong Provincial Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou 510515, China
| | - Z Zhang
- School of Biomedical Engineering//Guangdong Provincial Key Laboratory of Medical Image Processing//Guangdong Provincial Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou 510515, China
| | - Y Lu
- Central Laboratory, Southern Medical University, Guangzhou 510515, China
| | - J Geng
- School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
- Guangzhou Huayin Medical Laboratory Center, Guangzhou 510515, China
| | - Z Zhou
- Central Laboratory, Southern Medical University, Guangzhou 510515, China
| | - L Lu
- School of Biomedical Engineering//Guangdong Provincial Key Laboratory of Medical Image Processing//Guangdong Provincial Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou 510515, China
| | - L Cao
- School of Biomedical Engineering//Guangdong Provincial Key Laboratory of Medical Image Processing//Guangdong Provincial Engineering Laboratory for Medical Imaging and Diagnostic Technology, Southern Medical University, Guangzhou 510515, China
| |
Collapse
|
36
|
Shi J, Kraft P, Rosner BA, Benavente Y, Black A, Brinton LA, Chen C, Clarke MA, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Frias-Gomez J, Friedenreich CM, Garcia-Closas M, Goodman MT, Johnson L, La Vecchia C, Levi F, Lissowska J, Lu L, McCann SE, Moysich KB, Negri E, O'Connell K, Parazzini F, Petruzella S, Polesel J, Ponte J, Rebbeck TR, Reynolds P, Ricceri F, Risch HA, Sacerdote C, Setiawan VW, Shu XO, Spurdle AB, Trabert B, Webb PM, Wentzensen N, Wilkens LR, Xu WH, Yang HP, Yu H, Du M, De Vivo I. Risk prediction models for endometrial cancer: development and validation in an international consortium. J Natl Cancer Inst 2023; 115:552-559. [PMID: 36688725 PMCID: PMC10165481 DOI: 10.1093/jnci/djad014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2022] [Revised: 09/01/2022] [Accepted: 01/17/2023] [Indexed: 01/24/2023] Open
Abstract
BACKGROUND Endometrial cancer risk stratification may help target interventions, screening, or prophylactic hysterectomy to mitigate the rising burden of this cancer. However, existing prediction models have been developed in select cohorts and have not considered genetic factors. METHODS We developed endometrial cancer risk prediction models using data on postmenopausal White women aged 45-85 years from 19 case-control studies in the Epidemiology of Endometrial Cancer Consortium (E2C2). Relative risk estimates for predictors were combined with age-specific endometrial cancer incidence rates and estimates for the underlying risk factor distribution. We externally validated the models in 3 cohorts: Nurses' Health Study (NHS), NHS II, and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. RESULTS Area under the receiver operating characteristic curves for the epidemiologic model ranged from 0.64 (95% confidence interval [CI] = 0.62 to 0.67) to 0.69 (95% CI = 0.66 to 0.72). Improvements in discrimination from the addition of genetic factors were modest (no change in area under the receiver operating characteristic curves in NHS; PLCO = 0.64 to 0.66). The epidemiologic model was well calibrated in NHS II (overall expected-to-observed ratio [E/O] = 1.09, 95% CI = 0.98 to 1.22) and PLCO (overall E/O = 1.04, 95% CI = 0.95 to 1.13) but poorly calibrated in NHS (overall E/O = 0.55, 95% CI = 0.51 to 0.59). CONCLUSIONS Using data from the largest, most heterogeneous study population to date (to our knowledge), prediction models based on epidemiologic factors alone successfully identified women at high risk of endometrial cancer. Genetic factors offered limited improvements in discrimination. Further work is needed to refine this tool for clinical or public health practice and expand these models to multiethnic populations.
Collapse
Affiliation(s)
- Joy Shi
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Peter Kraft
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Bernard A Rosner
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
| | - Yolanda Benavente
- Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain
| | - Amanda Black
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - Louise A Brinton
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - Chu Chen
- Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Megan A Clarke
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - Linda S Cook
- Department of Epidemiology, Colorado School of Public Heath, University of Colorado-Anschutz, Aurora, CO, USA
- Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB, Canada
| | - Laura Costas
- Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain
| | - Luigino Dal Maso
- Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Aviano, Italy
| | - Jo L Freudenheim
- Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, The State University of New York at Buffalo, Buffalo, NY, USA
| | - Jon Frias-Gomez
- Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain
- Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain
| | - Christine M Friedenreich
- Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB, Canada
| | | | - Marc T Goodman
- Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - Lisa Johnson
- Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Carlo La Vecchia
- Department of Clinical Medicine and Community Health, Università degli Studi di Milano, Milan, Italy
| | - Fabio Levi
- Department of Epidemiology and Health Services Research, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland
| | - Jolanta Lissowska
- Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA
| | - Susan E McCann
- Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Kirsten B Moysich
- Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
| | - Eva Negri
- Department of Clinical Medicine and Community Health, Università degli Studi di Milano, Milan, Italy
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
| | - Kelli O'Connell
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Fabio Parazzini
- Department of Clinical Medicine and Community Health, Università degli Studi di Milano, Milan, Italy
| | - Stacey Petruzella
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Jerry Polesel
- Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Aviano, Italy
| | - Jeanette Ponte
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Timothy R Rebbeck
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Division of Population Science, Dana-Farber Cancer Institute, Boston, MA, USA
| | - Peggy Reynolds
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
| | - Fulvio Ricceri
- Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
| | - Harvey A Risch
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA
| | - Carlotta Sacerdote
- Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy
| | - Veronica W Setiawan
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Xiao-Ou Shu
- Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Amanda B Spurdle
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
- Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
| | - Britton Trabert
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
- Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, USA
| | - Penelope M Webb
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
| | - Nicolas Wentzensen
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | | | - Wang Hong Xu
- Department of Epidemiology, Fudan University School of Public Health, Shanghai, China
| | - Hannah P Yang
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - Herbert Yu
- University of Hawaii Cancer Center, Honolulu, HI, USA
| | - Mengmeng Du
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Immaculata De Vivo
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
- Radcliffe Institute for Advanced Study, Harvard University, Cambridge, MA, USA
| |
Collapse
|
37
|
Lu L, Zhang Q, Shen X, Zhen P, Marin A, Garcia-Milian R, Roper J, Khan SA, Johnson CH. Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer. bioRxiv 2023:2023.05.05.539577. [PMID: 37205388 PMCID: PMC10187315 DOI: 10.1101/2023.05.05.539577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
The nutrient status of the tumor microenvironment has major impacts on cell growth. Under nutrient depletion, asparagine synthetase (ASNS)-mediated asparagine production increases to sustain cell survival. G protein-coupled estrogen receptor-1 (GPER1) signaling converges via cAMP/PI3K/AKT with KRAS signaling to regulate ASNS expression. However, the role of GPER1 in CRC progression is still debated, and the effect of nutrient supply on both ASNS and GPER1 relative to KRAS genotype is not well understood. Here, we modeled a restricted nutrient supply by eliminating glutamine from growing cancer cells in a 3D spheroid model of human female SW48 KRAS wild-type (WT) and KRAS G12A mutant (MT) CRC cells, to examine effects on ASNS and GPER1 expression. Glutamine depletion significantly inhibited cell growth in both KRAS MT and WT cells; however, ASNS and GPER1 were upregulated in KRAS MT compared to WT cells. When nutrient supply was adequate, ASNS and GPER1 were not altered between cell lines. The impact of estradiol, a ligand for GPER1, was examined for any additional effects on cell growth. Under glutamine deplete conditions, estradiol decreased the growth of KRAS WT cells but had no effect on KRAS MT cells; estradiol had no additive or diminutive effect on the upregulation of ASNS or GPER1 between the cell lines. We further examined the association of GPER1 and ASNS levels with overall survival in a clinical colon cancer cohort of The Cancer Genome Atlas. Both high GPER1 and ASNS expression associated with poorer overall survival for females only in advanced stage tumors. These findings suggest that KRAS MT cells have mechanisms in place that respond to decreased nutrient supply, typically observed in advanced tumors, by increasing the expression of ASNS and GPER1 to drive cell growth. Furthermore, KRAS MT cells are resistant to the protective effects of estradiol under nutrient deplete conditions. ASNS and GPER1 may therefore be potential therapeutic targets that can be exploited to manage and control KRAS MT CRC.
Collapse
Affiliation(s)
- Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT 06520-8034 USA
| | - Qian Zhang
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
- Department of Colorectal Surgery, Second Affiliated Hospital Harbin Medical University, Heilongjiang Academy of Medical Science, Harbin, Heilongjiang Province 150086, China
| | - Xinyi Shen
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
| | - Pinyi Zhen
- Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
| | - Audrey Marin
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
| | - Rolando Garcia-Milian
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
- Bioinformatics Support Program, Yale School of Medicine, Yale University, New Haven, CT 06520, USA
| | - Jatin Roper
- Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina, USA; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, NC 27710, USA
| | - Sajid A Khan
- Section of Surgical Oncology, Department of Surgery, Yale School of Medicine, Yale Cancer Center, Yale University, New Haven, CT 06510, USA
| | - Caroline H Johnson
- Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520-8034, USA
| |
Collapse
|
38
|
Lu L, Risch E, Halaban R, Zhen P, Bacchiocchi A, Risch HA. Dynamic changes of circulating soluble PD-1/PD-L1 and its association with patient survival in immune checkpoint blockade-treated melanoma. Int Immunopharmacol 2023; 118:110092. [PMID: 37004344 DOI: 10.1016/j.intimp.2023.110092] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 03/10/2023] [Accepted: 03/22/2023] [Indexed: 04/03/2023]
Abstract
Immune checkpoint PD-1 and its ligand PD-L1 lead to T cell exhaustion, and a high level of circulating soluble PD-L1 at baseline indicates a poor prognosis in melanoma and other solid tumor types. Here we show that the dynamic changes of circulating soluble PD-1 and PD-L1 across the course of immune checkpoint blockades (ICBs) and their changes associate with patient survival in melanoma in a retrospective study. A high change of soluble PD-L1 level at a time-point but not PD-1 significantly increased the mortality, whereas a high change of soluble PD-1/PD-L1 ratio significantly reduced the mortality. After the initial immunotherapy, both soluble PD-1 and PD-L1 increased. However, the change pattern of soluble PD-L1 level was particularly dependent on patients' survival status. These findings indicate that the magnitudes of circulating soluble PD-L1 and PD-1/PD-L1 ratio changes over the time may reflect the patients' response to ICBs or the progression of the disease and predict the survival in melanoma patients treated with ICBs.
Collapse
|
39
|
Miao K, Cao WH, Lyu J, Yu CQ, Wang SF, Huang T, Sun DJY, Liao CX, Pang YJ, Pang ZC, Yu M, Wang H, Wu XP, Dong Z, Wu F, Jiang GH, Wang XJ, Liu Y, Deng J, Lu L, Gao WJ, Li LM. [A descriptive analysis of hyperlipidemia in adult twins in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:544-551. [PMID: 37147824 DOI: 10.3760/cma.j.cn112338-20221007-00859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
Objective: To describe the distribution characteristics of hyperlipidemia in adult twins in the Chinese National Twin Registry (CNTR) and explore the effect of genetic and environmental factors on hyperlipidemia. Methods: Twins recruited from the CNTR in 11 project areas across China were included in the study. A total of 69 130 (34 565 pairs) of adult twins with complete information on hyperlipidemia were selected for analysis. The random effect model was used to characterize the population and regional distribution of hyperlipidemia among twins. The concordance rates of hyperlipidemia were calculated in monozygotic twins (MZ) and dizygotic twins (DZ), respectively, to estimate the heritability. Results: The age of all participants was (34.2±12.4) years. This study's prevalence of hyperlipidemia was 1.3% (895/69 130). Twin pairs who were men, older, living in urban areas, married,had junior college degree or above, overweight, obese, insufficient physical activity, current smokers, ex-smokers, current drinkers, and ex-drinkers had a higher prevalence of hyperlipidemia (P<0.05). In within-pair analysis, the concordance rate of hyperlipidemia was 29.1% (118/405) in MZ and 18.1% (57/315) in DZ, and the difference was statistically significant (P<0.05). Stratified by gender, age, and region, the concordance rate of hyperlipidemia in MZ was still higher than that in DZ. Further, in within-same-sex twin pair analyses, the heritability of hyperlipidemia was 13.04% (95%CI: 2.61%-23.47%) in the northern group and 18.59% (95%CI: 4.43%-32.74%) in the female group, respectively. Conclusions: Adult twins were included in this study and were found to have a lower prevalence of hyperlipidemia than in the general population study, with population and regional differences. Genetic factors influence hyperlipidemia, but the genetic effect may vary with gender and area.
Collapse
Affiliation(s)
- K Miao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - W H Cao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - J Lyu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - C Q Yu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - S F Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - T Huang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - D J Y Sun
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - C X Liao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Y J Pang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Z C Pang
- Qingdao Municipal Center for Disease Control and Prevention, Qingdao 266033, China
| | - M Yu
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China
| | - H Wang
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China
| | - X P Wu
- Sichuan Center for Disease Control and Prevention, Chengdu 610041, China
| | - Z Dong
- Beijing Center for Disease Prevention and Control , Beijing 100013, China
| | - F Wu
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - G H Jiang
- Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - X J Wang
- Qinghai Center for Disease Prevention and Control , Xining 810007, China
| | - Y Liu
- Heilongjiang Provincial Center for Disease Control and Prevention, Harbin 150090, China
| | - J Deng
- Handan Center for Disease Control and Prevention of Hebei Province, Handan 056001, China
| | - L Lu
- Yunnan Center for Disease Control and Prevention, Kunming 650034, China
| | - W J Gao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - L M Li
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| |
Collapse
|
40
|
Wang YT, Cao WH, Lyu J, Yu CQ, Wang SF, Huang T, Sun DJY, Liao CX, Pang YJ, Pang ZC, Yu M, Wang H, Wu XP, Dong Z, Wu F, Jiang GH, Wang XJ, Liu Y, Deng J, Lu L, Gao WJ, Li LM. [A descriptive analysis on hypertension in adult twins in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:536-543. [PMID: 37147823 DOI: 10.3760/cma.j.cn112338-20221007-00860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
Objective: To describe the distribution characteristics of hypertension among adult twins in the Chinese National Twin Registry (CNTR) and to provide clues for exploring the role of genetic and environmental factors on hypertension. Methods: A total of 69 220 (34 610 pairs) of twins aged 18 and above with hypertension information were selected from CNTR registered from 2010 to 2018. Random effect models were used to describe the population and regional distribution of hypertension in twins. To estimate the heritability, the concordance rates of hypertension were calculated and compared between monozygotic twins (MZ) and dizygotic twins (DZ). Results: The age of all participants was (34.1±12.4) years. The overall self-reported prevalence of hypertension was 3.8%(2 610/69 220). Twin pairs who were older, living in urban areas, married, overweight or obese, current smokers or ex-smokers, and current drinkers or abstainers had a higher self-reported prevalence of hypertension (P<0.05). Analysis within the same-sex twin pairs found that the concordance rate of hypertension was 43.2% in MZ and 27.0% in DZ, and the difference was statistically significant (P<0.001). The heritability of hypertension was 22.1% (95%CI: 16.3%- 28.0%). Stratified by gender, age, and region, the concordance rate of hypertension in MZ was still higher than that in DZ. The heritability of hypertension was higher in female participants. Conclusions: There were differences in the distribution of hypertension among twins with different demographic and regional characteristics. It is indicated that genetic factors play a crucial role in hypertension in different genders, ages, and regions, while the magnitude of genetic effects may vary.
Collapse
Affiliation(s)
- Y T Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - W H Cao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - J Lyu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - C Q Yu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - S F Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - T Huang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - D J Y Sun
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - C X Liao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Y J Pang
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Z C Pang
- Qingdao Municipal Center for Disease Control and Prevention, Qingdao 266033, China
| | - M Yu
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China
| | - H Wang
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China
| | - X P Wu
- Sichuan Center for Disease Control and Prevention, Chengdu 610041, China
| | - Z Dong
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - F Wu
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336,China
| | - G H Jiang
- Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - X J Wang
- Qinghai Center for Disease Prevention and Control, Xining 810007, China
| | - Y Liu
- Heilongjiang Provincial Center for Disease Control and Prevention, Harbin 150090, China
| | - J Deng
- Handan Center for Disease Control and Prevention of Hebei Province, Handan 056001, China
| | - L Lu
- Yunnan Center for Disease Control and Prevention, Kunming 650034, China
| | - W J Gao
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - L M Li
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| |
Collapse
|
41
|
Wang H, Chang J, Zhang W, Fang Y, Li S, Fan Y, Jiang S, Yao Y, Deng K, Lu L, Bao X, Feng F, Wang R, Feng M. Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas. J Endocrinol Invest 2023:10.1007/s40618-023-02042-2. [PMID: 37020103 DOI: 10.1007/s40618-023-02042-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Accepted: 02/12/2023] [Indexed: 04/07/2023]
Abstract
OBJECTIVE Silent corticotroph adenomas (SCAs) are a subtype of nonfunctioning pituitary adenomas that exhibit more aggressive behavior. However, rapid and accurate preoperative diagnostic methods are currently lacking. DESIGN The purpose of this study was to examine the differences between SCA and non-SCA features and to establish radiomics models and a clinical scale for rapid and accurate prediction. METHODS A total of 260 patients (72 SCAs vs. 188 NSCAs) with nonfunctioning adenomas from Peking Union Medical College Hospital were enrolled in the study as the internal dataset. Thirty-five patients (6 SCAs vs. 29 NSCAs) from Fuzhou General Hospital were enrolled as the external dataset. Radiomics models and an SCA scale to preoperatively diagnose SCAs were established based on MR images and clinical features. RESULTS There were more female patients (internal dataset: p < 0.001; external dataset: p = 0.028) and more multiple microcystic changes (internal dataset: p < 0.001; external dataset: p = 0.012) in the SCA group. MRI showed more invasiveness (higher Knosp grades, p ≤ 0.001). The radiomics model achieved AUCs of 0.931 and 0.937 in the internal and external datasets, respectively. The clinical scale achieved an AUC of 0.877 and a sensitivity of 0.952 in the internal dataset and an AUC of 0.899 and a sensitivity of 1.0 in the external dataset. CONCLUSIONS Based on clinical information and imaging characteristics, the constructed radiomics model achieved high preoperative diagnostic ability. The SCA scale achieved the purpose of rapidity and practicality while ensuring sensitivity, which is conducive to simplifying clinical work.
Collapse
Affiliation(s)
- H Wang
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Neurospine center, China International Neuroscience Institute, Beijing, China
| | - J Chang
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
| | - W Zhang
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
- Department of Thoracic Surgery, Peking University First Hospital, Beijing, China
| | - Y Fang
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
| | - S Li
- Department of Plastic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China
| | - Y Fan
- Department of Neurosurgery, Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
| | - S Jiang
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
| | - Y Yao
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
| | - K Deng
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
| | - L Lu
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China
| | - X Bao
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China
| | - F Feng
- Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, China
| | - R Wang
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China.
| | - M Feng
- Department of Neurosurgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China.
| |
Collapse
|
42
|
Wang Z, Katsaros D, Wang J, Biglio N, Hernandez BY, Fei P, Lu L, Risch H, Yu H. Abstract 3020: Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival. Cancer Res 2023. [DOI: 10.1158/1538-7445.am2023-3020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2023]
Abstract
Abstract
Background: Host immunity involves various immune cells working in concert to achieve balanced immune response. Host immunity interacts with tumorigenic process impacting disease outcome. Clusters of different immune cells may indicate specific host-tumor interplay. Identifying the clusters may reveal unique host immunity in response to tumor growth.
Methods: CIBERSORT was used to estimate relative abundances of 22 immune cell types in 3 datasets, METABRIC, TCGA, and our study. The cell type data in METABRIC were analyzed for cluster using unsupervised hierarchical clustering (UHC). The UHC results were employed to train machine learning models, random forest (RF), deep neural network (DNN), stepAIC, and elastic net. Kaplan-Meier and Cox regression survival analyses were performed to assess cell clusters in association with relapse-free and overall survival. Differentially expressed genes (DEGs) by immune cell clusters were interrogated with IPA for molecular signatures.
Results: UHC analysis identified two distinct immune cell clusters, clusters A (83.2%) and B (16.8%). Memory B cells, plasma cells, CD8 positive T cells, resting memory CD4 T cells, activated NK cells, monocytes, M1 macrophages, and resting mast cells were more abundant in clusters A than B, whereas regulatory T cells and M0 and M2 macrophages were more in clusters B than A. Patients in cluster A had favorable survival compared to those in cluster B. Similar survival associations were also observed in TCGA and our study when using a RF model trained with the UHC results. The survival associations were independent from clinicopathological variables. IPA analysis showed that pathogen-induced cytokine storm signaling pathway, phagosome formation, and T cell receptor signaling were related to the cell type clusters.
Conclusions: Our finding suggests that different immune cell clusters may indicate distinct immune responses to tumor growth, suggesting their potential for disease management.
Citation Format: Zhanwei Wang, Dionyssios Katsaros, Junlong Wang, Nicholetta Biglio, Brenda Y. Hernandez, Peiwen Fei, Lingeng Lu, Harvey Risch, Herbert Yu. Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3020.
Collapse
Affiliation(s)
- Zhanwei Wang
- 1University of Hawai'i Cancer Center, Honolulu, HI
| | | | - Junlong Wang
- 1University of Hawai'i Cancer Center, Honolulu, HI
| | - Nicholetta Biglio
- 3University of Torino School of Medicine, Mauriziano Hospital, Turin, Italy
| | | | - Peiwen Fei
- 1University of Hawai'i Cancer Center, Honolulu, HI
| | - Lingeng Lu
- 4Yale School of Public Health, New Haven, CT
| | | | - Herbert Yu
- 1University of Hawai'i Cancer Center, Honolulu, HI
| |
Collapse
|
43
|
Zeng H, Wu S, Ma F, Ji JS, Lu L, Ran X, Shi J, Li D, An L, Zheng R, Zhang S, Chen W, Wei W, He Y, He J. Disparities in stage at diagnosis among breast cancer molecular subtypes in China. Cancer Med 2023; 12:10865-10876. [PMID: 36951474 DOI: 10.1002/cam4.5792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2022] [Revised: 02/08/2023] [Accepted: 02/27/2023] [Indexed: 03/24/2023] Open
Abstract
BACKGROUND Disease stage at diagnosis and molecular subtypes are the main determinants of breast cancer treatment strategies and prognosis. We aimed at examining the disparities and factors associated with the stage at diagnosis among the molecular subtypes in breast cancer patients in China. METHODS We identified patients with first primary breast cancer diagnosed between January 1, 2016, and December 31, 2017, from 23 hospitals in 12 provinces in China. We analyzed the proportion of non-early-stage (stages II-IV) breast cancer cases based on the family history of breast cancer, body mass index (BMI), insurance status, and molecular subtypes. Multivariable analyses were used to estimate the factors associated with non-early-stage diagnosis among the molecular subtypes. We further compared these estimates with that in the United States using the Surveillance, Epidemiology, and End Results database. RESULTS A total of 9398 Chinese were identified with first primary invasive breast cancer. Of the 8767 patients with known stages, the human epidermal growth factor receptor 2 (HER2)-enriched subtype had the highest proportion of stages II-IV (76.6%) patients, followed by triple-negative breast cancer (73.2%), luminal B (69.9%), and luminal A (62.3%). The percentage of non-early-stage patients was higher in women with overweight or obesity than in those with a body mass index (BMI) <25 kg/m2 (adjusted odds ratio [OR] 1.3, 95% confidence interval (CI) 1.1-1.4). Patients with a family history of breast cancer had a higher likelihood of early-stage (adjusted OR 0.7, 0.5-0.8) breast cancer. Patients with rural insurance had a substantially higher risk of non-early-stage disease than those with urban insurance (adjusted OR 1.8, 1.4-2.2). Regarding the subtype, being overweight/obese only increased the risk of non-early-stage in luminal A breast cancer. Compared with the United States, China had a higher proportion of non-early-stage breast cancer for all subtypes, with the largest gap in luminal A (adjusted OR 2.2, 95% CI 2.0-2.4). CONCLUSION The wide disparities in stage at breast cancer diagnosis imply that China urgently needs to improve early breast cancer diagnosis and health equity.
Collapse
Affiliation(s)
- Hongmei Zeng
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Siqi Wu
- Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, China
| | - Fei Ma
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - John S Ji
- Vanke School of Public Health, Tsinghua University, Beijing, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale Cancer Center, New Haven, Connecticut, USA
| | - Xianhui Ran
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Jin Shi
- Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, China
| | - Daojuan Li
- Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, China
| | - Lan An
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Rongshou Zheng
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Siwei Zhang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Wanqing Chen
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Wenqiang Wei
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Yutong He
- Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, China
| | - Jie He
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
44
|
Lu L, Zhong J, Wu X, Chen Q, Lin H, Chen L, Luo Y. [Resting heart rate correlates with major adverse cardiovascular and cerebrovascular events in patients with post-myocardial infarction ventricular aneurysms: a retrospective cohort study]. Nan Fang Yi Ke Da Xue Xue Bao 2023; 43:400-404. [PMID: 37087584 PMCID: PMC10122741 DOI: 10.12122/j.issn.1673-4254.2023.03.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
Abstract
OBJECTIVE To analyze the association of resting heart rate (RHR) with the prognosis of patients with post-infarction ventricular aneurysms. METHODS We retrospectively analyzed the clinical data of 227 patients with post-infarction ventricular aneurysms admitted to our hospital during 2017-2019. The endpoint event was the occurrence of any major adverse cardiovascular and cerebrovascular events (MACCEs) during the follow-up for 24 months. According to RHR measurements, the patients were divided into 3 groups with baseline RHR < 10%, 10%-90%, and >90%. The Cox proportional risk model and restricted cubic spline (RCS) model were used to analyze the effect of RHR on MACCEs. RESULTS During the 24-month followup, 90 patients (39.6%) experienced MACCEs. The fully adjusted RCS curves showed a nonlinear "U" shaped correlation between RHR and the occurrence of MACCEs. In the fully adjusted model, the risk of MACCEs increased by 3.01-fold (Hazard ratio [HR]=4.01, 95% CI: 2.07-7.76, P < 0.001) in patients with RHR>90%, as compared with patients with RHR of 10%-90%. In patients with RHR in 1-9th percentile, 10th-90th percentile and 91st-100th percentile, the incidences of MACCEs were 39.1%, 36.6% and 66.7% (P=0.027), the incidences of ventricular tachycardia/ventricular fibrillation (VT/VF) were 17.4%, 2.7% and 4.8% (P=0.005), and the incidences of readmission for heart failure were 8.7%, 26.8% and 42.9% (P=0.036), respectively. CONCLUSION Continuous monitoring and management of heart rate range may provide guidance for prognosis prediction in patients with post-infarction ventricular aneurysms.
Collapse
Affiliation(s)
- L Lu
- Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Fujian Heart Medical Center, Fuzhou 350001, China
- Fujian Institute of Coronary Artery Disease, Fuzhou 350001, China
| | - J Zhong
- Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Fujian Heart Medical Center, Fuzhou 350001, China
- Fujian Institute of Coronary Artery Disease, Fuzhou 350001, China
| | - X Wu
- Department of Neurology, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - Q Chen
- Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Fujian Heart Medical Center, Fuzhou 350001, China
- Fujian Institute of Coronary Artery Disease, Fuzhou 350001, China
| | - H Lin
- Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Fujian Heart Medical Center, Fuzhou 350001, China
- Fujian Institute of Coronary Artery Disease, Fuzhou 350001, China
| | - L Chen
- Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Fujian Heart Medical Center, Fuzhou 350001, China
- Fujian Institute of Coronary Artery Disease, Fuzhou 350001, China
| | - Y Luo
- Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou 350001, China
- Fujian Heart Medical Center, Fuzhou 350001, China
- Fujian Institute of Coronary Artery Disease, Fuzhou 350001, China
| |
Collapse
|
45
|
Lu L, Ma W, Johnson CH, Khan SA, Irwin ML, Pusztai L. In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer. Vaccine 2023; 41:2073-2083. [PMID: 36813666 PMCID: PMC10064809 DOI: 10.1016/j.vaccine.2023.02.048] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2022] [Revised: 02/12/2023] [Accepted: 02/14/2023] [Indexed: 02/22/2023]
Abstract
Somatic mutation-derived neoantigens are associated with patient survival in breast and ovarian cancer. These neoantigens are targets for cancer, as shown by the implementation of neoepitope peptides as cancer vaccines. The success of cost-effective multi-epitope mRNA vaccines against SARS-Cov-2 in the pandemic established a model for reverse vaccinology. In this study, we aimed to develop an in silico pipeline designing an mRNA vaccine of the CA-125 neoantigen against breast and ovarian cancer, respectively. Using immuno-bioinformatics tools, we predicted cytotoxic CD8+ T cell epitopes based on somatic mutation-driven neoantigens of CA-125 in breast or ovarian cancer, constructed a self-adjuvant mRNA vaccine with CD40L and MHC-I -targeting domain to enhance cross-presentation of neoepitopes by dendritic cells. With an in silico ImmSim algorithm, we estimated the immune responses post-immunization, showing IFN-γ and CD8+ T cell response. The strategy described in this study may be scaled up and implemented to design precision multi-epitope mRNA vaccines by targeting multiple neoantigens.
Collapse
Affiliation(s)
- Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT 06510, USA; Yale Cancer Center, Yale University, New Haven, CT 06510, USA.
| | - Wenxue Ma
- Department of Medicine, Moores Cancer Center and Sanford Stem Cell Clinical Center, University of California San Diego, La Jolla, CA 92093, USA
| | - Caroline H Johnson
- Yale Cancer Center, Yale University, New Haven, CT 06510, USA; Department of Environmental Health Science, Yale School of Public Health, Yale University, New Haven, CT 06510, USA
| | - Sajid A Khan
- Yale Cancer Center, Yale University, New Haven, CT 06510, USA; Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT 06510, USA
| | - Melinda L Irwin
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT 06510, USA; Yale Cancer Center, Yale University, New Haven, CT 06510, USA
| | - Lajos Pusztai
- Yale Cancer Center, Yale University, New Haven, CT 06510, USA; Department of Medical Oncology, Yale School of Medicine, Yale University, New Haven, CT 06510, USA
| |
Collapse
|
46
|
Han R, Li J, Hony J, Xiao Z, wang J, Yao M, Liang S, Lu L. CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment. Front Immunol 2023; 14:1052657. [PMID: 37006233 PMCID: PMC10061011 DOI: 10.3389/fimmu.2023.1052657] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2022] [Accepted: 03/01/2023] [Indexed: 03/18/2023] Open
Abstract
Hepatocellular carcinoma (HCC) is a lethal malignancy with a lack of effective treatments particularly for the disease at an advanced stage. Even though immune checkpoint inhibitors (ICIs) have made great progress in the treatment of HCC, durable and ideal clinical benefits still cannot be achieved in plenty of patients with HCC. Therefore, novel and refined ICI-based combination therapies are still needed to enhance the therapeutic effect. The latest study has reported that the carbonic anhydrase XII inhibitor (CAXIIi), a novel type of anticancer drug, can modify the tumor immunosuppression microenvironment by affecting hypoxic/acidic metabolism and alter the functions of monocytes and macrophages by regulating the expression of C-C motif chemokine ligand 8 (CCL8). These observations shine a light on improving programmed cell death protein 1 (PD-1)/programmed cell death ligand-1 (PD-L1) immunotherapy in combination with CAXIIis. This mini-review aims to ignite enthusiasm to explore the potential application of CAXIIis in combination with immunotherapy for HCC.
Collapse
Affiliation(s)
- Rui Han
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, China
- Department of Chinese Medicine, Naval Medical University, Shanghai, China
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States
- School of Medicine, Center for Biomedical Data Science, New Haven, CT, United States
- Yale Cancer Center, Yale University, New Haven, CT, United States
- *Correspondence: Rui Han, ; Lingeng Lu,
| | - Jiayin Li
- Department of Oncology, The First Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Jing Hony
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, China
- Department of Chinese Medicine, Naval Medical University, Shanghai, China
| | - Zhiwei Xiao
- Department of Oncology, The First Hospital Affiliated to Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Jinghui wang
- Department of Oncology, The First Hospital Affiliated to Guizhou University of Chinese Medicine, Guiyang, China
| | - Man Yao
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, China
- Department of Chinese Medicine, Naval Medical University, Shanghai, China
| | - Shufang Liang
- Department of Chinese Medicine Oncology, The First Affiliated Hospital of Naval Medical University, Shanghai, China
- Department of Chinese Medicine, Naval Medical University, Shanghai, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States
- School of Medicine, Center for Biomedical Data Science, New Haven, CT, United States
- Yale Cancer Center, Yale University, New Haven, CT, United States
- *Correspondence: Rui Han, ; Lingeng Lu,
| |
Collapse
|
47
|
Coward S, Benchimol EI, Bernstein C, Avina-Zubieta JA, Bitton A, Hracs L, Jones J, Kuenzig E, Lu L, Murthy SK, Nugent Z, Otley AR, Panaccione R, Pena-Sanchez JN, Singh H, Targownik LE, Windsor JW, Kaplan G. A35 FORECASTING THE INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASE: A CANADIAN NATION-WIDE ANALYSIS. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991201 DOI: 10.1093/jcag/gwac036.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background Canada is currently in the third epidemiological stage in the evolution of IBD: compounding prevalence. A high incidence of IBD, in conjunction with low mortality, leads to a steadily rising prevalence over time. By understanding historical epidemiological trends, we can forecast incidence and prevalence into the future to inform healthcare systems in Canada of the rising burden of IBD to society. Purpose To analyze past epidemiological trends in order to forecast the overall incidence and prevalence of IBD, Crohn’s disease (CD), and ulcerative colitis (UC) and stratified by age (<18, 18-64, 65+). Method Canadian population-based administrative data was acquired from: AB, BC, SK, MB, QC, and ON. Data were age and sex standardized to the matching year and provincial data aggregated into a representative sample of the Canadian population for prevalence (2002-2014) and incidence (2007-2014: 5-year washout period). Incidence and prevalence (per 100,000 persons) were calculated, with 95% confidence intervals (CI), using Canadian population estimates from Statistics Canada for IBD, CD, UC (IBD-unclassifiable+UC). Autoregressive Integrated Moving Average models were created, and rates forecasted from 2014 to 2035 with 95% prediction intervals (PI). Poisson (or negative binomial) for incidence and log binomial regression for prevalence estimated the Average Annual Percentage Change (AAPC), with 95% CIs, of the forecasted data. Result(s) The 2014 incidence of IBD in Canada was 28.4 per 100,000 (95%CI: 27.8, 29.0) and forecasted to significantly increase (AAPC: 0.58%; 95%CI: 0.04, 1.04) from 30.0 per 100,000 in 2023 to 32.1 (95%PI: 27.9, 36.3) in 2035. Pediatric onset IBD was 13.9 per 100,000 (95%CI: 13.0, 14.9) in 2014 and is forecasted to significantly increase to 18.0 per 100,000 (95%PI: 15.7, 20.2) in 2035 with an AAPC of 1.23% (95%CI: 0.76, 1.63). Adult and elderly onset incidence rates were forecasted to remain stable. Prevalence of IBD increased between 2002 (389 per 100,000) and 2014 (636 per 100,000) and is forecasted to continue to climb by an AAPC of 2.44% (95%CI: 2.34, 2.53). In 2023, the prevalence of IBD is 825 per 100,000. By 2035 prevalence is forecasted to climb to 1075 per 100,000 (95%PI: 1047, 1103) with 470,000 Canadians living with IBD. Prevalence across all age strata were forecasted to significantly increase. The highest AAPC was seen in the elderly (2.76%; 95%CI: 2.73, 2.79) with a prevalence of 841 per 100,000 (95%CI: 834, 849) in 2014 and forecasted to climb to 1534 per 100,000 (95%PI: 1519, 1550) in 2035. Image ![]()
Conclusion(s) Incidence of IBD continues to rise in Canada, driven by pediatric-onset IBD. In 2023, over 320,000 Canadians (0.83%) will be living with IBD. By 2035 prevalence will exceed 1% of the population with approximately 470,000 individuals in Canada with IBD. Future research should establish the environmental determinates of IBD that may influence temporal trends in the incidence of IBD, while healthcare systems adapt to the compounding prevalence of IBD. Please acknowledge all funding agencies by checking the applicable boxes below CIHR, Other Please indicate your source of funding; The Leona M. and Harry B. Helmsley Charitable Trust Disclosure of Interest S. Coward: None Declared, E. Benchimol Consultant of: Hoffman La-Roche Limited and Peabody & Arnold LLP for matters unrelated to medications used to treat inflammatory bowel disease and McKesson Canada and the Dairy Farmers of Ontario for matters unrelated to medications used to treat inflammatory bowel disease., C. Bernstein Grant / Research support from: Unrestricted educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, Bristol Myers Squibb Canada, and Takeda Canada. Has received research grants from Abbvie Canada, Amgen Canada, Pfizer Canada, and Sandoz Canada and contract grants from Janssen, Abbvie and Pfizer, Consultant of: Abbvie Canada, Amgen Canada, Bristol Myers Squibb Canada, JAMP Pharmaceuticals, Janssen Canada, Pfizer Canada, Sandoz Canada, and Takeda., Speakers bureau of: Abbvie Canada, Janssen Canada, Pfizer Canada and Takeda Canada, J. A. Avina-Zubieta: None Declared, A. Bitton: None Declared, L. Hracs: None Declared, J. Jones Consultant of: Janssen, Abbvie, Pfizer, Takeda, Speakers bureau of: Janssen, Abbvie, Pfizer, Takeda, E. Kuenzig: None Declared, L. Lu: None Declared, S. Murthy: None Declared, Z. Nugent: None Declared, A. Otley Grant / Research support from: Unrestricted educational grants from AbbVie Canada and Janssen Canada, Consultant of: Advisory boards of AbbVie Canada, Janssen Canada and Nestle, R. Panaccione Consultant of: Abbott, AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pendopharm, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Theravance Biopharma, Trellus, Viatris, UCB. Advisory Boards for: AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Speakers bureau of: AbbVie, Amgen, Arena Pharmaceuticals, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Gilead Sciences, Janssen, Merck, Organon, Pfizer, Roche, Sandoz, Shire, Takeda Pharmaceuticals, J.-N. Pena-Sanchez: None Declared, H. Singh Consultant of: Pendopharm, Amgen Canada, Bristol Myers Squibb Canada, Roche Canada, Sandoz Canada, Takeda Canada, and Guardant Health, Inc., L. Targownik Grant / Research support from: Investigator initiated funding from Janssen Canada, Consultant of: [Advisory board] AbbVie Canada, Takeda Canada, Merck Canada, Pfizer Canada, Janssen Canada, Roche Canada, and Sandoz Canada, J. Windsor: None Declared, G. Kaplan Grant / Research support from: Ferring, Janssen, AbbVie, GlaxoSmith Kline, Merck, and Shire, Consultant of: Gilead, Speakers bureau of: AbbVie, Janssen, Pfizer, Amgen, and Takeda
Collapse
Affiliation(s)
| | | | | | | | | | - L Hracs
- University of Calgary, Calgary
| | - J Jones
- Dalhousie University, Halifax
| | - E Kuenzig
- The Hospital for Sick Children, Toronto
| | - L Lu
- Arthritis Research Canada, Winnipeg
| | | | - Z Nugent
- University of Manitoba, Winnipeg
| | | | | | | | - H Singh
- University of Manitoba, Winnipeg
| | | | | | | |
Collapse
|
48
|
Coward S, Benchimol EI, Bernstein C, Avina-Zubieta JA, Bitton A, Hracs L, Jones J, Kuenzig E, Lu L, Murthy SK, Nugent Z, Otley AR, Panaccione R, Pena-Sanchez JN, Singh H, Targownik LE, Windsor JW, Kaplan G. A210 THE BURDEN OF IBD HOSPITALIZATION IN CANADA: AN ASSESSMENT OF THE CURRENT AND FUTURE BURDEN IN A NATION-WIDE ANALYSIS. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991188 DOI: 10.1093/jcag/gwac036.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background Hospitalizations pose a significant burden on both the individual and the healthcare system. Those with inflammatory bowel disease (IBD) are at increased risk of hospitalization as compared to the general population due to flaring of disease activity and complications related to IBD. The advent of biologics over the past twenty years may have influenced the rates of hospitalization for IBD. Purpose To assess current and forecast the overall hospitalization rates of those with IBD stratified by types of hospitalizations (all cause hospitalizations, IBD-related, and IBD-specific). Method Population-based administrative data on hospitalization of IBD (2002-2014) were obtained from: AB, BC, MB, and SK. Data were age and sex standardized to the matching year and aggregated into a representative sample of the Canadian population. Hospitalization rates were assessed as follows: 1. All cause hospitalizations: all admissions regardless of indication; 2. IBD-specific: an admission directly resulting from IBD (e.g., IBD-flare); 3. IBD-related: an admission for IBD, or a symptom or comorbidity associated with IBD (e.g. rheumatoid arthritis). Using prevalence estimates from the provinces, hospitalization rates (per 100 persons with IBD) were calculated, with 95% confidence intervals (CI). Autoregressive Integrated Moving Average models were created to estimate number of hospitalizations and corresponding prevalence to forecast hospitalization rates to 2030 with 95% prediction intervals (PI). Poisson (or negative binomial) regression estimated the Average Annual Percentage Change (AAPC), with 95% CIs, of the forecasted data. Result(s) In 2002 there were 35.3 per 100 (95%CI: 34.7, 35.9) all cause hospitalizations for IBD patients and this decreased to 24.9 per 100 (24.5, 25.2) in 2014. Similar trends were seen for IBD-specific hospitalizations [16.8 per 100 (95%CI: 16.4, 17.2) in 2002 to 8.7 per 100 (95%CI: 8.5, 9.0) in 2014] and IBD-related (22.6 per 100 (95%CI: 22.1, 23.1) in 2002 to 13.4 per 100 (95%CI: 13.2, 13.7) in 2014). When forecasted out to 2030 all hospitalization types were significantly decreasing—the AAPC for all cause hospitalizations was -2.12% (95%CI: -2.31, -1.93), -3.77% (95%CI: -4.63, -3.08) for IBD-specific, and -3.09% (95%CI: -3.65, -2.62) for IBD-related. By 2030, the rates of hospitalization are forecasted to be 17.0 per 100 (95%PI: 16.2, 17.9), 4.6 per 100 (95%PI: 3.7, 5.4), and 7.9 per 100 (95%PI: 6.9, 8.9) for all cause, IBD-specific, and IBD-related, respectively. Image ![]()
Conclusion(s) In Canada, rates of hospitalizations for those with IBD have decreased from 2002 to 2014. The use of anti-TNF therapy in conjunction with the evolution of clinical monitoring, management and guidelines, likely has contributed to dropping hospitalization rates. Forecast models estimate a continued drop in hospitalization rates out to 2030. Importantly, healthcare resource planning should account for the shift from hospital-based to clinic-centric models of IBD care. Please acknowledge all funding agencies by checking the applicable boxes below CIHR Disclosure of Interest S. Coward: None Declared, E. Benchimol Consultant of: Hoffman La-Roche Limited and Peabody & Arnold LLP for matters unrelated to medications used to treat inflammatory bowel disease and McKesson Canada and the Dairy Farmers of Ontario for matters unrelated to medications used to treat inflammatory bowel disease., C. Bernstein Grant / Research support from: Unrestricted educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, Bristol Myers Squibb Canada, and Takeda Canada. Has received research grants from Abbvie Canada, Amgen Canada, Pfizer Canada, and Sandoz Canada and contract grants from Janssen, Abbvie and Pfizer, Consultant of: Abbvie Canada, Amgen Canada, Bristol Myers Squibb Canada, JAMP Pharmaceuticals, Janssen Canada, Pfizer Canada, Sandoz Canada, and Takeda., Speakers bureau of: Abbvie Canada, Janssen Canada, Pfizer Canada and Takeda Canada, J. A. Avina-Zubieta: None Declared, A. Bitton: None Declared, L. Hracs: None Declared, J. Jones Consultant of: Janssen, Abbvie, Pfizer, Takeda, Speakers bureau of: Janssen, Abbvie, Pfizer, Takeda, E. Kuenzig: None Declared, L. Lu: None Declared, S. Murthy: None Declared, Z. Nugent: None Declared, A. Otley Grant / Research support from: Unrestricted educational grants from AbbVie Canada and Janssen Canada, Consultant of: Advisory boards of AbbVie Canada, Janssen Canada and Nestle, R. Panaccione Consultant of: Abbott, AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pendopharm, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Theravance Biopharma, Trellus, Viatris, UCB. Advisory Boards for: AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Speakers bureau of: AbbVie, Amgen, Arena Pharmaceuticals, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Gilead Sciences, Janssen, Merck, Organon, Pfizer, Roche, Sandoz, Shire, Takeda Pharmaceuticals, J.-N. Pena-Sanchez: None Declared, H. Singh Consultant of: Pendopharm, Amgen Canada, Bristol Myers Squibb Canada, Roche Canada, Sandoz Canada, Takeda Canada, and Guardant Health, Inc.,, L. Targownik Grant / Research support from: Investigator initiated funding from Janssen Canada, Consultant of: [Advisory board] AbbVie Canada, Takeda Canada, Merck Canada, Pfizer Canada, Janssen Canada, Roche Canada, and Sandoz Canada, J. Windsor: None Declared, G. Kaplan Grant / Research support from: Ferring, Janssen, AbbVie, GlaxoSmith Kline, Merck, and Shire, Consultant of: Gilead, Speakers bureau of: AbbVie, Janssen, Pfizer, Amgen, and Takeda
Collapse
Affiliation(s)
| | | | | | | | | | - L Hracs
- University of Calgary, Calgary
| | - J Jones
- Dalhousie University, Halifax
| | - E Kuenzig
- The Hospital for Sick Children, Toronto
| | - L Lu
- Arthritis Research Canada, Vancouver
| | | | - Z Nugent
- University of Manitoba, Winnipeg
| | | | | | | | - H Singh
- University of Manitoba, Winnipeg
| | | | | | | |
Collapse
|
49
|
Coward S, Benchimol EI, Bernstein C, Avina-Zubieta JA, Bitton A, Hracs L, Jones J, Kuenzig E, Lu L, Murthy SK, Nugent Z, Otley AR, Panaccione R, Pena-Sanchez JN, Singh H, Targownik LE, Windsor JW, Kaplan G. A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS. J Can Assoc Gastroenterol 2023. [PMCID: PMC9991147 DOI: 10.1093/jcag/gwac036.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/09/2023] Open
Abstract
Background Inflammatory bowel disease (IBD) is a costly disease to manage due to hospitalizations, regular ambulatory monitoring, and expensive pharmaceutical therapies. While hospitalization rates have fallen, the increased use of biologics have escalated the cost of care to the healthcare system. Purpose To assess historical direct healthcare costs of the IBD population in Canada. Method Population-based administrative costing data were obtained from: Alberta, British Columbia, and Manitoba. Costs were calculated based on administrative data (2009 to 2016) which captured: hospitalizations, physician costs, ambulatory care such as: emergency visits, day surgery, and colonoscopy (AB only), and medication costs of IBD-specific medications, such as: mesalamine, biologics, steroids, and immunomodulators. Costs were converted to 2020 dollars using the consumer price index. Average annual cost per person (ACPP) was calculated for each province. Using province specific IBD prevalence estimates these ACPP were meta-analyzed to obtain the annual weighted costs, with 95% confidence intervals (CI), and these costs underwent meta-regression to ascertain the average annual change in cost per year. An Autoregressive Integrated Moving Average model was created to estimate the ACPP in 2023 with 95% prediction intervals (PI). Canada-wide total direct care costs of IBD patients, in billions (B), were calculated using the ACPP, Canada-specific IBD prevalence estimates (historical and forecasted), and total Canadian population calculations from Statistics Canada (historical and forecasted). Result(s) In 2009 the ACPP was $7000 (95%CI: 5389, 8610), representing $1.18B (95%CI: 0.91B, 1.45B) in direct healthcare costs in Canada for all IBD patients. The ACPP in 2016 was increased to $10,336 (95%CI: 6803, 13869), which equates to $2.37B (95%CI: 1.56B, 3.18B) per year in direct healthcare costs. From 2009 to 2016, the ACPP increased an average of $450 (95%CI: 132, 767) per year. If these historical trends continue to 2023 the ACPP is forecasted to be $13,333 (95%PI: 12827, 13839) per person per year. The largest contributor to these costs is medications—accounting for an estimated 50% of the total costs of IBD patients. Image ![]()
Conclusion(s) The direct healthcare cost of IBD has risen steadily from 2009 to 2016 when the healthcare system spent over $10,000 per person with IBD and $2.37B nationwide. The primary driver of costs is medical management. Forecast models estimate that the annual cost may be over $13,000 per person in 2023. However, these estimates do not account for advent and increased uptake of novel biologics and small molecules, nor the downward cost pressure of biosimilars. These costs are those paid directly by the healthcare system and do not account for those born by the individual—it is estimated that the true cost of IBD (direct and indirect) is much higher. Please acknowledge all funding agencies by checking the applicable boxes below CIHR Disclosure of Interest S. Coward: None Declared, E. Benchimol Consultant of: Hoffman La-Roche Limited and Peabody & Arnold LLP for matters unrelated to medications used to treat inflammatory bowel disease and McKesson Canada and the Dairy Farmers of Ontario for matters unrelated to medications used to treat inflammatory bowel disease., C. Bernstein Grant / Research support from: Unrestricted educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, Bristol Myers Squibb Canada, and Takeda Canada. Has received research grants from Abbvie Canada, Amgen Canada, Pfizer Canada, and Sandoz Canada and contract grants from Janssen, Abbvie and Pfizer, Consultant of: Abbvie Canada, Amgen Canada, Bristol Myers Squibb Canada, JAMP Pharmaceuticals, Janssen Canada, Pfizer Canada, Sandoz Canada, and Takeda., Speakers bureau of: Abbvie Canada, Janssen Canada, Pfizer Canada and Takeda Canada, J. A. Avina-Zubieta: None Declared, A. Bitton: None Declared, L. Hracs: None Declared, J. Jones Consultant of: Janssen, Abbvie, Pfizer, Takeda, Speakers bureau of: Janssen, Abbvie, Pfizer, Takeda, E. Kuenzig: None Declared, L. Lu: None Declared, S. Murthy: None Declared, Z. Nugent: None Declared, A. Otley Grant / Research support from: Unrestricted educational grants from AbbVie Canada and Janssen Canada, Consultant of: Advisory boards of AbbVie Canada, Janssen Canada and Nestle, R. Panaccione Consultant of: Abbott, AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pendopharm, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Theravance Biopharma, Trellus, Viatris, UCB. Advisory Boards for: AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Speakers bureau of: AbbVie, Amgen, Arena Pharmaceuticals, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Gilead Sciences, Janssen, Merck, Organon, Pfizer, Roche, Sandoz, Shire, Takeda Pharmaceuticals, J.-N. Pena-Sanchez: None Declared, H. Singh Consultant of: Pendopharm, Amgen Canada, Bristol Myers Squibb Canada, Roche Canada, Sandoz Canada, Takeda Canada, and Guardant Health, Inc.,, L. Targownik Grant / Research support from: Investigator initiated funding from Janssen Canada, Consultant of: [Advisory board] AbbVie Canada, Takeda Canada, Merck Canada, Pfizer Canada, Janssen Canada, Roche Canada, and Sandoz Canada, J. Windsor: None Declared, G. Kaplan Grant / Research support from: Ferring, Janssen, AbbVie, GlaxoSmith Kline, Merck, and Shire, Consultant of: Gilead, Speakers bureau of: AbbVie, Janssen, Pfizer, Amgen, and Takeda
Collapse
Affiliation(s)
| | | | | | | | | | - L Hracs
- University of Calgary, Calgary
| | - J Jones
- Dalhousie University, Halifax
| | - E Kuenzig
- The Hospital for Sick Children, Toronto
| | - L Lu
- Arthritis Research Canada, Vancouver
| | | | - Z Nugent
- University of Manitoba, Winnipeg
| | | | | | | | - H Singh
- University of Manitoba, Winnipeg
| | | | | | | |
Collapse
|
50
|
An L, Zheng R, Zhang S, Chen R, Wang S, Sun K, Lu L, Zhang X, Zhao H, Zeng H, Wei W, He J. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries. Hepatobiliary Surg Nutr 2023; 12:45-55. [PMID: 36860251 PMCID: PMC9944524 DOI: 10.21037/hbsn-21-75] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Accepted: 06/03/2021] [Indexed: 11/06/2022]
Abstract
Background Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most common subtypes of primary liver cancer, but nationwide incidence of both liver cancer subtypes have never been reported in China. We aimed to estimate the most recent incidence of HCC and ICC and temporal trends in China based on the most updated data from high qualified population-based cancer registries (covering 13.1% of the national population), in comparison to those in the United States at the same period. Methods We used data from 188 Chinese population-based cancer registries covering 180.6 million population of China to estimate the nationwide incidence of HCC and ICC in 2015. And 22 population-based cancer registries' data were used to estimate the trends of HCC and ICC incidence from 2006 to 2015. Multiple imputation by chained equations method was used to impute liver cancer cases with unknown subtype (50.8%). We used data from 18 population-based registries from the Surveillance, Epidemiology, and End Results program to analyze incidence of HCC and ICC in the United States. Results In China, an estimated 301,500 and 61,900 newly diagnosed HCC and ICC occurred in 2015. The overall age-standardized rates (ASRs) of HCC incidence decreased by 3.9% per year. For ICC incidence, the overall ASR was relatively stable, but increased in the population of over 65 years old. Subgroup analysis by age showed that the ASR of HCC incidence had the sharpest decline in population who were less than 14 years old and received neonatally hepatitis B virus (HBV) vaccination. In the United States, though the incidence of HCC and ICC were lower than those in China, the overall HCC and ICC incidence increased by 3.3% and 9.2% per year. Conclusions China still faces with a heavy burden of liver cancer incidence. Our results may further support the beneficial effect of Hepatitis B vaccination on reduction of HCC incidence. Both healthy lifestyle promotion and infection control are needed for future liver cancer control and prevention for China and the United States.
Collapse
Affiliation(s)
- Lan An
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Rongshou Zheng
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Siwei Zhang
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Ru Chen
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Shaoming Wang
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Kexin Sun
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Lingeng Lu
- Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale Cancer Center, Yale University, New Haven, CT, USA
| | - Xuehong Zhang
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA;,Department of Nutrition, T. H. Chan School of Public Health, Harvard University, Boston, MA, USA
| | - Hong Zhao
- Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Hongmei Zeng
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Wenqiang Wei
- National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Jie He
- Department of Thoracic Surgery, National Cancer Registry Office, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|